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Carpal tunnel syndrome (CTS) is a neuropathy in which the median nerve is compressed at the 
level of the carpal tunnel.1,2 The carpal tunnel is an anatomical space in the wrist, surrounded 
by the carpal bones and the transverse carpal ligament.3 The compression of the median nerve 
within this tunnel leads to the typical symptoms of numbness, paresthesia and sometimes pain 
in the patient’s hand. The symptoms are usually sensed in the first three fingers and the radial 
side of the ring finger, because these areas are innervated by the median nerve.2 Severity of 
the symptoms can range from mild and annoying to very painful, and they can be unilateral or 
bilateral. Initially, the symptoms present at night and awaken patients from sleep.3 When the 
condition progresses, the symptoms persist during the day and may be aggravated by (heavy) 
activities involving the hand or wrist. When the nerve is compressed for a longer period of time, 
nerve degeneration and thenar atrophy may occur.2
CTS is very common; the prevalence in the general population in the United States is 5%,4 and 
in Netherlands about 0.6% in men and between 5.8 and 9.2% in women.5-7 In general, it is more 
prevalent in women compared to men, and although CTS can occur at any age, it most com-
monly arises between 40 and 60 years.1
Pathophysiology and clinical neurophysiology 
CTS can be either idiopathic (spontaneous) or secondary to another disorder. Several theories 
have been proposed, but the common belief is that idiopathic CTS is caused by mechanical 
compression and subsequent ischemia. Long-term, this results in demyelination, inflammation 
and fibrosis. The median nerve and flexor tendons run through the carpal tunnel parallel to each 
other, affecting the other’s dynamics. Wear and degeneration of the tendons with age possibly 
cause edema and fibrosis. This increases the tissue volume within the carpal tunnel, compress-
ing the median nerve.8 Nerve compression leads to microvascular dysfunction and subsequent 
endoneurial edema, demyelination, inflammation, distal axonal degeneration, fibrosis, growth of 
new axons, remyelination, and thickening of the perineurium and endothelium.9 
The diagnosis of CTS is primarily based on history and patient-reported clinical signs and symp-
toms.3,8 Patients commonly report the typical symptoms of numbness, paresthesia and pain in 
the distribution of the median nerve.3 More severe cases may also present with persisting sensory 
symptoms, weakness and thenar muscle atrophy. Several clinical tests are used to support the 
diagnosis of CTS (such as Tinel’s sign and Phalen test), but they have major limitations in sensitiv-
ity and specificity.10 Electrodiagnostic testing (EDT) is used as an objective measure to support 
the diagnosis.11 EDT is considered the ‘gold standard’ among the diagnostic tests.12 Compression 
of the median nerve leads to damage and dysfunction of the myelin sheath, which results in 
slowed conduction velocity. Nerve conduction velocity can be measured using EDT. The nerve is 
stimulated by an electrical impulse through the skin, resulting in an action potential in the nerve. 
The wave of depolarization is then detected over a certain distance by a recording electrode. 
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Latency times of the median nerve across the wrist are recorded and compared to a reference 
value or latency time of another nerve segment which does not pass through the carpal tunnel. 
There are universal criteria for the diagnostic values of EDT.11 However, EDT also has its limita-
tions: false positives and false negatives are not uncommon.1,13 Another promising diagnostic 
technique is ultrasonography of the median nerve.14,15 With this technique, the cross-sectional 
area of the median nerve can be measured, which is enlarged in CTS patients. Contrary to EDT, 
sonography is painless and can detect possible underlying (anatomical) abnormalities. Although 
sonography has several advantages over EDT, it is not yet widely used in clinical practice. 
Risk factors: CTS during pregnancy
In most cases, CTS is idiopathic.3,14 However, some conditions are known to predispose to CTS. 
Mass lesions and anatomical variants can cause an increase in tissue volume within the carpal 
tunnel or a decrease in size of the carpal tunnel itself. Obesity is a known risk factor for CTS, espe-
cially in younger patients.16,17 Specific diseases that affect the synovium and can cause secondary 
CTS include diabetes mellitus, rheumatoid arthritis, tenosynovitis and hypothyroidism.8,14,18 The 
prevalence of CTS among hypothyroid patients is over 30%.19,20 It is suspected that CTS has a 
genetic component, although the supportive evidence is sparse.21Another frequently reported 
risk factor for CTS is pregnancy. Pregnancy-related CTS (PRCTS) is more often bilateral22-24 and 
typically occurs during the third trimester,22,25 although the onset can be as early as the first tri-
mester in some cases. The true prevalence of PRCTS is unclear. According to a systematic review 
by Padua et al., the prevalence of electrophysiologically confirmed PRCTS ranges from 7 to 43%, 
while the prevalence of clinically diagnosed PRCTS ranges from 31 to 62%.26 The reason for this 
variation is probably the different methods and diagnostic criteria. Several causes of PRCTS have 
been suggested, including hormonal and musculoskeletal changes.25,27 The predominant belief, 
however, is that PRCTS is caused by local edema in the carpal tunnel during pregnancy.22,24,28 
As stated above, hypothyroidism is a risk factor for CTS in the general population. Hypothyroid-
ism is an endocrine disorder characterized by low levels of free thyroid hormone called thyroxine 
(FT4). Thyroid hormone plays an important role in the regulation of metabolism.29 In hypothyroid 
patients, CTS is most likely caused by (myxo)edema in the carpal tunnel and subsequent neu-
ropathy.30 During pregnancy, FT4 levels decrease towards end of term as a natural physiological 
phenomenon.31 Moreover, obesity is a risk factor for developing CTS in the non-pregnant popu-
lation. Pop et al.29 showed that FT4 and BMI were negatively correlated during pregnancy. They 
also found a significant association between inappropriate weight gain and lower FT4 levels 
during pregnancy. Whether the weight gain can be attributed to the metabolic effects of lower 
FT4 or an effect of lower FT4 on fluid retention or edema during pregnancy remains to be clari-
fied. Altogether, it does suggest a possible relation between thyroid function and CTS during 
pregnancy, although the nature of this relationship has not been investigated yet. 
CTS is possibly an under recognized problem during pregnancy, as reflected by poor insight 




providers.32 Moreover, the clinical implications of PRCTS are unclear. Even though symptoms 
are generally mild compared to the non-pregnant population,23 34-75% report impairment of 
hand function and the symptoms may also contribute to sleep problems during pregnancy.32,33 
The best ‘solution’ for pregnancy-related CTS is delivery. The symptom severity quickly reduces 
in the first weeks postpartum22 and symptoms are believed to resolve completely in time,34 but 
clear figures on persisting CTS symptoms postpartum are hardly available. Between 4% and 54% 
of women report persisting symptoms at one year postpartum.26,27,34,35 Padua et al.35 suggested 
that women with onset of symptoms earlier in pregnancy are more likely to have persisting 
symptoms postpartum. 
We conducted a large prospective cohort study among pregnant women: the HAPPY study 
(Holistic Approach to Pregnancy and the first Postpartum Year). Psychological and physiologi-
cal data were collected to investigate determinants that may interfere with maternal and child 
well-being during pregnancy and postpartum. In this thesis, we focused on the prevalence and 
nature of CTS symptoms, and possible predictors and negative effects of these symptoms dur-
ing pregnancy and postpartum. Emotional status is another possible predictor that needs to be 
considered when assessing self-reported sensory symptoms. Depression, for example, can influ-
ence the subjective experience of pain,36 also in pregnant women.37 People with chronic pain 
(>3 months) reported more psychological problems, including depression, compared to healthy 
controls.38 Depression was also a predictor of symptom severity in CTS patients.39,40 Therefore, 
it is important to consider depressive symptoms when assessing self-reported CTS symptoms. 
Current treatment options for CTS
Treatment options for CTS can be divided into surgical and non-surgical. Non-surgical, less 
invasive treatment options are often offered as initial treatment for patients with mild to moder-
ate symptoms or a short duration of symptoms. The most common non-surgical interventions 
are wrist splinting and steroid injections at the inlet of the carpal tunnel. A wrist splint is often 
applied at night and stabilizes the wrist in a neutral position because the pressure on the median 
nerve increases during wrist flexion and extension, and is lowest in a neutral position.41 Steroid 
injections are used to reduce inflammation-induced swelling in the carpal tunnel, and thereby 
relieving pressure on the median nerve. Both splinting and steroid injections are effective short-
term, but there is little evidence for their effectiveness long-term.41-44 Local steroid injections 
seem to primarily suppress the symptoms because the treatment effect often diminishes over 
time.43,45 However, patients with an electrodiagnostically mild case of CTS may benefit from 
steroid injections long-term.46 Other (less traditional) forms of non-surgical treatment include 
non-steroidal drugs, exercise and mobilization interventions, therapeutic ultrasound, yoga, 
carpal bone mobilization, vitamins, magnet therapy, laser acupuncture and chiropractic care.47,48 
Most of the evidence for these interventions is very limited or of low quality. 
To this date, surgery is the only known treatment option for CTS that is effective at long-term.49 
The principle of the procedure, called carpal tunnel release, is to cleave the transverse carpal 
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ligament, thereby increasing the volume in the carpal tunnel and reducing pressure on the 
median nerve.7 This can be accomplished using two different techniques: open or endoscopic 
carpal tunnel release. The procedure is usually performed unilateral and under local anesthesia. 
Although surgery is considered the best treatment option, especially when conservative treat-
ment has failed, it is associated with several risks. Patients can suffer sustained surgery-related 
pain, hypertrophic scar, hand weakness or complications from surgery, such as wound infec-
tion.50 Between 20 and 30% of patients are unsatisfied with the surgery outcome.6,8,51-53 They ex-
perience persistence or recurrence of symptoms or suffer from surgery-related complications.8,52 
Up to 12% of patients require re-operation.52 
To the best of our knowledge, there are no randomized controlled trials comparing carpal tunnel 
release surgery to no treatment or sham surgery. A small number of RCTs have compared surgery 
to conservative treatment.49,54,55 Hui et al.55 randomly assigned 50 patients with electrophysi-
ologically confirmed idiopathic CTS to surgery or a single steroid injection. Surgery resulted in 
greater symptom reduction than steroid injection at 20 weeks follow-up. Contrary, Ly-Pen et al.56 
showed a greater treatment benefit from steroid injection compared to surgery at three months 
follow-up and no difference at one year follow-up in an RCT with 163 wrists with clinically and 
electrophysiologically confirmed CTS. Surgery led to significantly lower self-reported symptom 
severity than non-surgical treatment (anti-inflammatory) drugs, hand therapy and ultrasound 
therapy at six months follow-up in an RCT by Jarvik et al.49 However, they reported that the 
clinical relevance of the difference was only modest. Gerritsen et al.5 found that surgery was 
more effective than splinting at three and 18 months follow-up. In their study, 67% of patients 
had adverse effects after surgery, although they were generally mild and short of duration. Two 
of 54 patients, however, had severe pillar pain and one patient had reflex sympathetic dystrophy, 
which can be considered to be severe adverse effects. 
Mechanical traction
A promising and relatively new non-invasive treatment for CTS is mechanical wrist traction. Dur-
ing this treatment, repeated traction movements are applied to the wrist in different positions 
using gravitational force. The treatment comprises a series of treatment sessions, with one or 
two sessions per week. A session takes 10 to 15 minutes per affected hand. Figure 1 presents and 
image of the traction device that was used, the Phystrac. 
Mechanical traction has several advantages. First, it is non-invasive: in general, patients do not 
experience any pain or discomfort from the treatment and they are able to continue their work 
and other daily activities for the duration of the treatment. Secondly, patients with bilateral 
symptoms can be treated on both hands during the same session. Thirdly, the treatment can 
be tailored to individual patients: the weight of the gravitational force and the number of treat-
ments can vary depending on individual needs. Finally, if the treatment fails, there is still an 




Brunarski et al.57 described four case studies using mechanical traction that showed promising 
results. In an observational study in the Netherlands among 78 CTS patients in a practice for 
physical therapy, treatment with mechanical traction resulted in a post-treatment success rate 
of 70%,58 and 60% after two years follow-up.59 Symptom severity scores and functional scores de-
creased significantly after treatment, especially in patients with a shorter duration of complaints. 
However, no randomized controlled trial had been performed to provide clinical evidence for 
the effectiveness of mechanical traction compared to other (non-)surgical interventions. We 
therefore conducted an RCT comparing 12 sessions of mechanical traction to care as usual in an 
outpatient neurology clinic in the Netherlands.
How to measure treatment outcome in CTS patients
Electrodiagnostic testing (EDT) is a useful tool to support a clinical diagnosis of CTS, but is less 
valuable as an outcome measurement for treatment effect. It is time-consuming, relatively 
expensive and can create temporary discomfort for the patient. Moreover, the only meaningful 
measure of treatment effect in CTS patients is the patient-reported improvement in symptoms.51 
In 1993, Levine et al.60 published a new self-administered questionnaire for the assessment of CTS 
symptoms: the Boston Carpal Tunnel Questionnaire (BCTQ). Six critical domains were identified: 
pain, paresthesia, numbness, weakness, nocturnal symptoms and functional status. Two differ-
ent subscales were therefore developed: the Symptom Severity Scale (SSS) and the Functional 
Status Scale (FSS). The SSS comprises 11 questions about symptom severity, including pain and 
paresthesia during the day and at night, numbness and weakness. The FSS comprises eight daily 
activities which are rated on degree of difficulty. All activities are common and performed by 
a large variety of people, including young adults to elderly. Levine et al.60 tested the reproduc-
ibility, internal consistency and responsiveness to clinical change, which was later confirmed 
in a systematic review by De Carvalho Leite et al.61 in 2006. It is an easy, quick, standardized, 
patient-centered, user-friendly and inexpensive measure that can be compared across stud-
ies. The BCTQ is therefore widely used in studies concerning treatment effect in CTS patients, 
although sometimes under a different name. The BCTQ is also referred to as Levine scale, Carpal 




Tunnel Questionnaire or Carpal Tunnel Syndrome Instrument.61 We have used a Dutch version of 
the BCTQ for all the chapters of this thesis. The Dutch version has previously been used in other 
studies.6,43 
aims and outlines of this thesis
This thesis focusses on the prevalence, determinants and possible consequences of CTS during 
pregnancy, based on data of the HAPPY study. Moreover, the design and outcomes of a random-
ized controlled trial involving mechanical traction, a non-invasive treatment option for CTS, in an 
outpatient (non-pregnant) neurologic CTS population are described.
Pregnancy is a known risk factor for CTS, but prevalence rates of CTS during pregnancy vary be-
tween 1 and 62% in the current literature due to methodological flaws. Therefore, in Chapter 2, 
we investigated the prevalence of CTS symptoms during pregnancy in a large sample of healthy 
pregnant women. 
Hypothyroidism is another known risk factor for CTS in the non-pregnant population, but the 
relation between thyroid function and CTS has not been investigated in pregnancy. In Chapter 3, 
we investigated the relationship between thyroid function and CTS symptoms during pregnancy. 
In Chapter 2, we describe that the one in three women report CTS symptoms during pregnancy, 
but the possible negative effects of these symptoms on the well-being of mother and child are 
unknown. Therefore, we describe the possible impact of CTS symptoms during late pregnancy on 
breastfeeding initiation in Chapter 4.
CTS symptoms in pregnancy are believed to quickly resolve after birth. However, some women 
may experience persisting CTS symptoms postpartum. In Chapter 5, we report the prevalence of 
persisting pregnancy-related CTS symptoms in our cohort of pregnant women. Possible predictors 
of CTS at 12 months postpartum were also investigated. 
Carpal tunnel release surgery is the only known long-term effective treatment, but it is invasive and 
up to 30% of patients report recurrence or persistence of symptoms or suffer from post-surgical 
complications. A promising non-surgical treatment for CTS is mechanical wrist traction. In Chapter 
6, we describe the design of a randomized controlled trial in a non-pregnant outpatient neurologic 
population investigating the effectiveness of mechanical wrist traction as a non-surgical treatment 
compared to care as usual in CTS patients. Chapter 7 describes the results of this trial. 
Finally, the main results of this thesis are summarized in Chapter 8, and clinical implications of 
the results and suggestions for future research are discussed. 
an overview of the used samples
Between January 2013 and September 2014, a total of 2,221 pregnant women were included in 
the HAPPY study. These women were followed during pregnancy up to one year postpartum. 
They filled out questionnaires at 12, 22 and 32 weeks’ gestation and at 1 week, 6 weeks, 4, 8 
and 12 months postpartum. Figure 2 presents a flow chart of the available CTS-related data at 




symptoms were assessed using the BCTQ at 32 weeks’ gestation and postpartum. Moreover, 
thyroid parameters were assessed at 12 and 32 weeks’ gestation. Table 1 provides an overview of 
the measurements and time points.
For the RCT investigating the effectiveness of mechanical traction, we recruited adult patients 
(men and women) with electrophysiologically confirmed CTS from an outpatient neurology 
clinic in the Netherlands. A total of 181 patients were randomly assigned to the intervention 
group (mechanical traction) or the control group (care as usual). Participants in the interven-
tion group received 12 treatments with mechanical traction during six consecutive weeks. They 
completed questionnaires at baseline and 3, 6 and 12 months follow-up. Figure 3 provides a flow 
chart of the inclusions. 
The sample presented in Figure 3 was used in Chapter 7. 
Figure 2 Flow chart for the CTS-related data of the HAPPY study. 
Table 1 Time points of CTS(-related) assessments during pregnancy up to 12 months postpartum. 
Pregnancy Postpartum
12 wks 22 wks 32 wks 1 wk 6 wks 4 mnths 8 mnths 12 mnths
Presence of CTS symptoms X X X X X X
BCTQa X X
Depression (EDSb) X X X X X X X X
Thyroid function parameters X X
a Boston Carpal Tunnel Questionnaire, only in women with CTS symptoms. b Edinburgh Depression Scale. 
Chapter 1
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Prevalence, course and determinants of carpal 
tunnel syndrome symptoms during pregnancy: 
a prospective study
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Objective: To investigate the prevalence, severity and relation to fluid retention of self-reported 
pregnancy-related carpal tunnel syndrome (CTS) symptoms in a large sample of pregnant 
women.
Design: A prospective longitudinal cohort study. 
Setting: Dutch women who became pregnant between January 2013 and January 2014 in the 
southeast of the Netherlands. 
Population or Sample: A total of 639 Dutch pregnant women.
Methods: Baseline characteristics were assessed at 12 weeks’ gestation. CTS symptoms were 
assessed using the Boston Carpal Tunnel Questionnaire (BCTQ) at 32 weeks and during the first 
postpartum week regarding the last weeks of pregnancy. Fluid retention, sleeping problems 
and depressive symptoms (using the Edinburgh Depression Scale) were assessed at several time 
points during pregnancy. 
Main Outcome Measures: BCTQ scores, fluid retention and sleeping problems. 
Results: Of the 639 women, 219 (34%) reported CTS symptoms during pregnancy. Total mean 
scores on the BCTQ were significantly higher after 32 weeks than up to 32 weeks’ gestation. 
Most women experienced mild to moderate symptoms. Pregnant women with CTS symptoms 
reported significantly higher levels of fluid retention during gestation compared to pregnant 
women without CTS symptoms (F = 60.6, df {1, 598}, p <.001), adjusted for body mass index (BMI) 
age, parity and depression scores. Higher scores on fluid retention throughout the pregnancy 
were significantly related to CTS (OR = 1.8, 95% CI [1.5-2.1], p <.001). Finally, the occurrence of 
CTS was independently related to sleeping problems.
Conclusions: Although the severity of symptoms and functional impairment of CTS were rela-
tively mild, health care professionals should be aware of the high prevalence. The occurrence of 
CTS symptoms is significantly higher in women who report fluid retention during gestation and 
it can contribute to sleeping problems.
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INTRODUCTION 
In patients with carpal tunnel syndrome (CTS) the median nerve is compressed in the carpal 
tunnel, leading to the key symptoms of tingling, pain and a numb feeling in the first three fingers 
and the radial side of the fourth finger.1,2 CTS occurs in 4% of the general population3 and 10% 
of the working population.4 Risk factors for CTS are obesity, diabetes mellitus and rheumatoid 
arthritis.2 In general, CTS is objectively diagnosed by means of electrodiagnostic testing (EDT). 
Compression of the median nerve leads to a slowed conduction velocity at the carpal tunnel 
due to dysfunction of the myelin sheath, which can be measured using EDT.5 
CTS occurs frequently during pregnancy: pregnancy-related CTS (PRCTS). PRCTS is often 
bilateral6-8 and mostly present in the third trimester.7,9,10 Although the true cause of PRCTS is 
unknown, it is believed that the symptoms are caused by local edema in the carpal tunnel due to 
hormonal changes.6,7,10,11 Reported prevalence rates of PRCTS vary between <1% up to 62%.8-11 
According to a recent systematic review by Padua et al 12, the prevalence of PRCTS based on 
clinical symptoms ranges between 31% and 62%, whereas electrophysiologically confirmed 
PRCTS ranges between 7% and 43%. This variety is explained partly by methodological aspects 
of assessing PRCTS, but the most important reason is patient- and doctor-delay: women do not 
report symptoms and physicians do not ask for them.13 This means that figures based on patient 
record forms in general result in underestimation of PRCTS. 
When assessing physical health problems in general, and in pregnant women in particular, it is 
important to be aware of mental health problems. Pregnant women are particularly at risk for 
depression: up to 10-15% of them suffer from depression, which is often not recognized.14 It is 
well known from clinical experience and scientific research that patients with undiagnosed (and 
hence not properly treated) depression often report a substantial amount of somatic symptoms, 
including various pain symptoms. 
The primary aim of the present prospective study was to study the prevalence of self-reported 
CTS symptoms in a large sample of pregnant women. The secondary outcome was the nature 
and severity of symptoms and functional impairment. The tertiary outcome was to investigate 
the possible relation between self-reported fluid retention and CTS complaints, adjusted for the 
occurrence of depression. Finally, a possible negative effect of CTS symptoms on the sleeping 
patterns during gestation was evaluated. 
METHODS
Participants 
From January 2013 to January 2014, Dutch-speaking Caucasian pregnant women were recruited 
from 17 community midwife practices in the region of Eindhoven, the southeast of the Nether-
lands, during their first prenatal visit. Women with multifetal pregnancy, previously diagnosed 
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endocrine disorders, severe psychiatric disease, HIV, or drug or alcohol addiction were excluded 
from the study. The full study protocol has been approved by the Psychology Ethics Committee 
of the School of Social and Behavioral Sciences of Tilburg University. All participating pregnant 
women (and their partners) received written and oral information and signed written informed 
consent.
Because the prevalence of PRCTS ranges so widely in the literature, sample size was calculated 
using a conservative estimated prevalence of 2.5% to increase precision. A total of 600 women 
needed to be included. The characteristics of the participants are shown in Table 1. As can be 
seen in Table 1, the number of primiparous women was similar to multiparous women and 
nearly 90% of the women were <35 years of age. Pregnant women with CTS symptoms did not 
Table 1 Characteristics of the 639 pregnant women included in the study. 
Characteristic n (%) Mean SD
Demographic features






Educational level      
high 443 (69.3)
low 196 (30.7)
Marital status      
With partner 632 (98.9)
Job   594 (93.0)    
Obstetric features
Parity        
Primiparous 316 (49.5)
Previous abortion 146 (22.8)    
Unplanned pregnancy 33 (5.2)    
Lifestyle habits during pregnancy
Smoking   11 (1.7)    
Alcohol   12 (1.9)    
BMI pre-pregnancy   23.8 3.8
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differ significantly from the rest of the study sample based on baseline characteristics, except 
BMI pre-pregnancy (p = .01). 
assessments of baseline characteristics and pregnancy-related symptoms 
At 12 weeks’ gestation, the participating pregnant women completed a questionnaire to assess 
baseline characteristics (demographic, lifestyle habits and current and previous obstetric char-
acteristics). At 12, 22 and 32 weeks’ gestation and during the first postpartum week regarding 
the last weeks of pregnancy, the participants completed a questionnaire containing a variety 
of complaints which are generally mentioned during gestation. The items were scored on a 
five-point Likert scale ranging from not at all (0) to very severe (4). The items “fluid retention in 
hands and/or feet” fluid retention in general”, “problems falling asleep” and “problems continuing 
sleeping” were used to evaluate a possible association with CTS, the first two as a plausible 
explanation of CTS and the last two as a possible negative outcome of CTS. At 32 weeks’ gesta-
tion, the women were asked for the three key symptoms of CTS during the previous period 
of gestation: “Did you suffer any of the following symptoms during pregnancy: pain, tingling 
sensations, or numbness in hands or wrists?”. Moreover, they were asked if the symptoms were 
bilateral and at what term of gestation they started. Subsequently, the positive cases (excluding 
those who responded with ‘’not at all’’ to the key question) completed the Boston Carpal Tunnel 
Questionnaire (BCTQ) to evaluate the severity of symptoms as well as hand function impairment. 
At the end of the first postpartum week the questionnaire was also used to evaluate the last 
weeks of pregnancy. 
The boston Carpal Tunnel Questionnaire 
The BCTQ consists of two different scales: the Symptom Severity Scale (SSS, 11 items) and the 
Functional Status Scale (FSS, 8 items).15,16 Both scales are answered on a five-point Likert scale. 
The total score on the two subscales is calculated by dividing the absolute score by the number 
of items: 11-55/11 for symptom severity and 8-40/8 for functional status.16 The BCTQ is equally 
useful in predicting CTS as EDT,17 providing a simple and quick measure to assess CTS symptoms. 
The BCTQ has previously been validated in the Netherlands.18
The Edinburgh Depression Scale 
At 12, 22 and 32 weeks’ gestation, the occurrence of depressive symptoms was evaluated by 
means of the Edinburgh Depression Scale (EDS). The EDS was originally developed to assess 
depression in the postpartum period (EPDS) and was translated and validated for use in the 
Netherlands.19 It has been shown that it has adequate psychometric properties to assess depres-
sive symptoms during pregnancy as well.20 The EDS consists of 10 items with total score ranges 
from 0 to 30, with higher scores indicating more symptoms of depression. A commonly used 




Data were analyzed using SPSS 20.0 (SPSS Inc., Chicago, IL). As there was very few missing data 
(2%), only completed cases were analyzed. Descriptive data are presented as frequencies and 
corresponding percentages or means and standard deviations. Differences between groups 
were analyzed using t-tests for continuous variables. To assess the relationship between fluid re-
tention during pregnancy and the presence of self-reported CTS symptoms (CTS +/-), repeated 
measures ANOVA was used. A p-value <.05 was considered significant. The sum scores of the 
two items related to fluid retention (fluid retention in hands/feet and in general) were computed 
for all four time points (range 0-8). Subsequently, a multiple logistic regression analysis was 
performed, with CTS +/- as the dependent variable and the grand mean of fluid retention (at all 
time points) during pregnancy as independent variable, adjusted for age, parity, BMI and depres-
sion. Finally, the possible relation between sleeping problem scores and CTS was investigated 
at univariate level using independent t-tests and at multivariate level using linear regression 
analysis, adjusting for depression, age, parity and BMI. The grand mean of sleeping problems at 
both time points (before and after 32 weeks) was computed using the sum scores of the two 
items (falling asleep and continuing sleeping), and was used as dependent variable (range 0-8).
RESULTS
In the present study, 219 of 639 women (34%) reported one or more of the three key symptoms 
of CTS during pregnancy. Of these 219 cases, 66 (30%) reported unilateral and 153 (70%) bilateral 
symptoms. Only 16 women (7% of the cases) reported the onset of symptoms before 12 weeks, 
30 (14%) between 12 and 20 weeks, 86 (39%) between 21 and 30 weeks, and 87 (40%) after 30 
weeks. 
Of the symptomatic pregnant women, 114 (52%) cases were primiparous and 105 (48%) mul-
tiparous, of whom 27 (26%) reported having suffered from CTS symptoms during a previous 
pregnancy. Mean scores (total mean divided by number of items) on the symptom severity scale 
(SSS) and function status scale (FSS) up to and after 32 weeks’ gestation were compared. Up to 32 
weeks, the mean score was 1.5 (0.6) for the SSS and 1.3 (0.6) for the FSS. After 32 weeks, the mean 
score was 1.8 (0.7) for the SSS and 1.4 (0.6) for the FSS. Significantly higher levels of symptoms and 
functional impairment were reported after 32 weeks’ gestation than in the first two trimesters 
(t = -6.335, p <.001 for SSS, t = -3.689, p <.001 for FSS). Moreover, the mean levels of severity of 
symptoms were significantly higher than the mean levels of functional impairment (t = 7.573, p 
<.001 before 32 weeks, t = 11.765, p <.001 after 32 weeks). During all trimesters, the women were 
asked whether they looked for medical help for any reason. Only 4 women reported to have 
consulted their physician because of CTS symptoms. BCTQ scores were not different between 
multiparous women who experienced CTS symptoms in a previous pregnancy compared with 
multiparous women who experienced CTS symptoms for the first time (data not shown). 
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The nature and severity of CTS symptoms in 219 cases using the BCTQ subscales are reported 
in Figure 1A and 1B. In Figure 1A, the prevalence and severity of six most typical CTS symptoms 
are shown. As can be seen, the most prevalent symptom was tingling sensations at night (65% 
>32 weeks), while pain during the night was reported in 49%. Overall, the severity of symptoms 
increased with increasing term. Most women experienced mild to moderate symptoms; severe 
and very severe symptoms were hardly reported. The severity of complaints was the highest 
for numbness and tingling sensations during the day and at night. After 32 weeks, 20 women 
(9%) reported the tingling sensations during the day to be severe or very severe. All symptoms 
increased in severity during the last eight weeks of pregnancy. 
The degree of functional impairment is presented in Figure 1B. As can be seen, very severe 
functional impairment was rare, but women experienced more functional impairment during 
the last weeks of their pregnancy than before 32 weeks. For each of the activities, more than 
half of the women reported never having problems. There was no difference of reported CTS 
symptoms (both severity as well as functional) between primiparous and multiparous women 
(data not shown). 
At 12, 22 and 32 weeks’ gestation, the number of women suffering from depression (EDS score 
>11) was 64 (10%), 70 (11%) and 57 (9%), respectively. Mean scores of the EDS at different trimes-
ters were 4.4 (4.1), 5.2 (4.2) and 4.9 (4.0), respectively.
In Figure 2, mean scores on the fluid retention items during pregnancy of women with and 
without CTS are presented, adjusted for BMI, age, parity and depression scores on the EDS. At 
all four time points mean scores on self-reported fluid retention were higher in the group of 
women with CTS symptoms than in the group without symptoms. Repeated measures ANOVA 
showed that pregnant women with CTS symptoms reported significantly higher levels of fluid 
retention during gestation compared with pregnant women without CTS symptoms (F = 60.6, 
df {1, 598}, p <.001 ).
Subsequently, a multiple logistic regression analysis was performed with CTS +/- as dependent 
variable and mean fluid retention throughout pregnancy as independent variable, adjusted for 
age, BMI, parity and depression scores during gestation. Only higher scores of fluid retention 
throughout pregnancy were significantly related to CTS (OR = 1.8, 95% CI [1.5-2.1], p <.001). 
The mean scores of sleeping problems were significantly higher in the CTS group than in the 
non-CTS group: 3.1 (1.8) versus 2.8 (1.8), respectively (t = -2.048, p = .038). Finally, a multiple linear 
regression revealed that the grand mean of the BCTQ scores predicted sleeping problems (β = 
.087, p = .025) as well as higher scores of depression symptoms on the EDS during gestation (β = 


































































































































































































































In the present study, the prevalence of self-reported carpal tunnel syndrome symptoms dur-
ing pregnancy was 34%. Overall, the severity of symptoms increased with increasing term. For 
most women, the severity of symptoms was relatively mild and functional impairment was 
not frequently reported. Moreover, women with CTS symptoms reported higher levels of fluid 
retention during gestation compared with women without CTS symptoms. Furthermore, logistic 
regression results showed that for every unit increase in the mean score of self-reported fluid 
retention throughout pregnancy, women were almost twice as likely to report CTS symptoms. 
Finally, CTS had an independent negative effect on sleep during the last trimester.
Strengths and limitations
Strengths of this study are the prospective design, the repeated measurements, the adjustment 
for comorbid depressive symptoms and the large sample size: 639 healthy pregnant women 
were included in the study, providing considerable power and an accurate representation of 
the general population. Moreover, the study provides information about the prevalence as well 































Figure 2 Estimated marginal means (repeated measures ANOVA) of the symptom fluid retention in 639 pregnant 
women assessed at 12, 22, 32 and after 32 weeks’ gestation comparing those with CTS symptoms (CTS +, n = 219) 
and without CTS symptoms (CTS -, n = 420), adjusted for BMI, age, parity and depression. 
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of self-reported CTS symptoms but also the severity and possible disability in hand function. 
The BCTQ has extensively been tested and has proved to have similar qualities as EDT.17 This 
patient-friendly questionnaire made it possible to assess large samples of patients. An important 
finding was the increasing severity of the symptoms during the last weeks of pregnancy. This 
means that the last weeks of pregnancy should be taken into account when assessing CTS. Also, 
reported symptoms (CTS, fluid retention and sleeping problems) were corrected for depression. 
The study has several limitations. First, the BCTQ was completed at only two time points: at 32 
weeks’ gestation and during the first postpartum week. The questionnaire was not conducted 
at the other two time points earlier in pregnancy (12 and 22 weeks). However, it is well known 
that CTS rarely develops early in pregnancy.7,9,10 Secondly, CTS was not diagnosed either clinically 
or using EDT. However, clinical tests such as the Tinel sign or Phalen’s test have been reported 
to have poor sensitivity and specificity.6,25 In clinical practice, the most important diagnostic 
criteria are patient reported symptoms. Concannon et al.26 reported that the majority of patients 
with a clinical diagnosis of CTS but with a negative electrodiagnostic test benefitted from surgi-
cal release. Moreover, a questionnaire concerning the most typical CTS symptoms has been 
proved to have a similar sensitivity, specificity and positive predictive value as EDT.27 As EDT is 
considered relatively invasive and time-consuming, the use of a questionnaire as a sensitive 
alternative is appropriate for pregnant women. Thirdly, only Caucasian women were included 
in the study, which limits the generalizability of the results. According to a recent meta-analysis, 
non-Caucasian people are at higher risk for CTS.27 
Interpretation 
Fluid retention increased during gestation in all women, which is consistent with the normal 
physiological pattern during pregnancy. The amount of weight gained between 20 and 30 
weeks of pregnancy is largely attributed to an increase in maternal fat stores. After 30 weeks, 
an increase in extravascular fluid leads to greater weight gain.21 This explains why CTS symp-
toms most commonly present after 30 weeks’ gestation. In the present study, 40% of the cases 
reported the onset of symptoms after 30 weeks. Multiparous women with a previous history of 
CTS symptoms did not show a higher severity of CTS symptoms in the current pregnancy. In the 
current study, only (multiparous) women who reported CTS symptoms were asked for possible 
symptoms during earlier pregnancies. There is no evidence in the literature that the occurrence 
of CTS symptoms in a previous pregnancy always results in the recurrence of symptoms in a 
future pregnancy. However, within one woman there is a substantial individual variation of 
weight gain (fluid retention) between subsequent pregnancies. It is possible that a woman 
with a previous history of CTS during pregnancy might have had a substantially higher weight 
increase during that pregnancy. Unfortunately, we did not register the figures of weight gain 
during a previous pregnancy.
The reported prevalence of PRCTS symptoms is comparable to the prevalence range reported 
by Padua et al.12 (31-62% clinically diagnosed PRCTS). Compared with the general population, 
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the prevalence of PRCTS is substantially higher. While only 4% of the general population suffers 
from CTS,3 the prevalence is almost nine times higher in our study sample (pregnant women in 
the general population).  
The severity of symptoms and functional impairment is relatively mild compared with the non-
pregnant CTS population. Jarvik et al.22 reported a mean score of 2.81 on the SSS and 2.32 on 
the FSS in their study of the general population (n = 323). These scores are considerably higher 
than the mean scores during the last weeks of pregnancy reported in this study (1.8 and 1.4 
on the SSS and FSS, respectively). Padua et al.11 also reported lower severity and impairment 
in pregnant women than in non-pregnant women with CTS. This is probably the main reason 
why PRCTS is underdiagnosed: women with mild symptoms are less likely to ask for medical 
care. The most commonly reported symptoms presented at night: 65% of women reported 
tingling sensations at night, and pain during the night was reported by 49%. As previously has 
been reported, these symptoms interfere with sleep.6 The current study also shows that CTS is 
independently related to poorer sleeping patterns. Sleep disturbance, especially during the last 
trimester, interferes with quality of life and might also exhaust women, representing a possible 
risk of a troublesome delivery. Moreover, sleeping problems in general make people vulnerable 
to mental problems such as depression and anxiety. Future research could focus on the impact 
of CTS on the quality of life and a possible impact on mode of delivery. As CTS symptoms can 
be treated conservatively,23 it is important to recognize the problem during pregnancy. Patients 
can wear a wrist splint, which stabilizes the wrist in a neutral position, maximizing the volume 
in the carpal tunnel and decreasing pressure on the nerve.9 More than 80% of pregnant women 
experience considerable symptoms relief using a splint at night, thereby improving quality of 
sleep.6Moreover, steroid injections offer temporary symptom relief in most women9. Although 
serious side effects have never been reported, pregnant women do not readily accept this type 
of intervention. Surgery is hardly ever performed during pregnancy,23 because many women 
experience symptom relief after delivery.12 During the last decade, another non-invasive treat-
ment has been developed for CTS: traction and rotation to the wrist using a mechanical trac-
tion device. This is a patient-friendly method that is currently being researched (described in 
detail elsewhere).29 If proven effective, health care professionals will have another non-invasive 
treatment especially suitable for pregnant women with CTS. Ultimately, the best treatment is 
delivery. The fact that women with PRCTS symptoms reported significantly more severe fluid 
retention supports the attribution of PRCTS symptoms to local edema in the carpal tunnel due 
to hormonal changes.6,7,10,11 
The trimester-specific prevalence ranges as well as the mean scores on the EDS are similar to 
other studies using the EDS.20,24 It has repeatedly been reported that the number of women with 
depression (EDS >11) as well as the means scores decrease towards end term, which was also 
the case in the current study.14 The fact that women with CTS reported higher scores of fluid 
retention independently of depression scores means that reporting CTS is unlikely to be related 
to depressed mood. To the best of our knowledge, there are no reports in the literature of stud-
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ies investigating the possible effect of depression on reporting CTS symptoms in the general 
non-pregnant population. However, as it is well known that depression influences reporting 
symptoms of pain, we considered it appropriate to control for depression. The current design 
showed that depression scores did not interfere with the relation between CTS and fluid reten-
tion. This further supports a physiological explanation for CTS.   
Conclusion
Although the severity of PRCTS is relatively mild, the prevalence of self-reported CTS symptoms 
during pregnancy is high, and the severity and functional impairment can easily be assessed by 
means of a self-rating questionnaire. CTS is strongly related to the presence of fluid retention. 
Severe functional impairment due to CTS symptoms is not frequently reported during preg-
nancy, but many women experience tingling sensations in their hands or wrists, especially at 
night, contributing to sleeping problems. Health care professionals should be aware of the high 
prevalence and the increase of symptom severity of CTS with increasing term, as symptoms can 
be treated effectively with conservative treatment during pregnancy. 
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Objective: To investigate the relationship between thyroid function, fluid retention and CTS in 
pregnant women.
Methods: Dutch women who had their first antenatal visit at one of 17 participating community 
midwife offices in the Netherlands were included in this prospective longitudinal cohort study, 
with inclusion period from January 2013 till September 2014. A sample of 1,269 women were 
followed during pregnancy up until the first postpartum week. Thyroid hormone levels (TSH, 
FT4 and TPO-antibodies) were measured at 12 and 32 weeks. Fluid retention and CTS symptoms 
were measured using self-report at 12, 22 and 32 weeks’ gestation, and one week postpartum 
regarding the last weeks of pregnancy. 
Results: In the present study, 452 of 1,269 women (36%) reported CTS symptoms during preg-
nancy. Of the thyroid parameters, FT4 at 12 and 32 weeks’ gestation were significantly related 
to CTS. Multiple logistic regression analysis showed that lower levels of FT4 (OR = 0.88, 95% CI 
[0.80-0.97]), higher fluid retention scores throughout pregnancy (OR = 1.78, 95% CI [1.57-2.02]) 
and higher depression scores (OR = 1.05, 95% CI [1.01-1.09]) were significantly related to CTS. 
Moreover, within the group of women who reported CTS symptoms, the intensity of the symp-
toms were significantly correlated with thyroid hormone levels at 32 weeks and fluid retention 
scores. 
Conclusions: Lower levels of FT4 are associated with a higher prevalence of CTS. The association 
between FT4 and CTS was independent of fluid retention. These results indicate that thyroid 
function in the lower reference range contributes to CTS during pregnancy.
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INTRODUCTION
Carpal tunnel syndrome (CTS) is the second most common musculoskeletal condition during 
pregnancy.1 The median nerve may become compressed at the level of the carpal tunnel, lead-
ing to tingling, paresthesia and pain in the median nerve distribution.2,3 CTS is much more com-
mon in pregnant women compared to the non-pregnant female population4 but the prevalence 
rates vary substantially in the literature (1-62%).5-8 We have recently reported a prevalence of 34% 
in a large sample of pregnant women.9 CTS often presents in the later stages of pregnancy, spe-
cifically during the third trimester.5,8,10 It has repeatedly been suggested that the high prevalence 
during pregnancy is related to fluid retention with increasing term.1,7-10 
Thyroid function, especially overt hypothyroidism, has been related to CTS.11-13 The prevalence 
of CTS among hypothyroid patients is over 30%,11,13 while only 4% of the general population 
suffers from CTS.14 Because the time delay between the onset of hypothyroid function and the 
diagnosis of hypothyroidism in general is substantial, it is hypothesized that, due to (myxo)
edema in the carpal tunnel, compression of the median nerve occurs resulting in neuropathy 
and as a consequence CTS symptoms.1,10 In pregnancy, thyroid hormone levels decrease during 
gestation.15 However, the role of thyroid function in relation to pregnancy-related CTS has never 
been investigated. 
In the current study, we investigated a relation between maternal thyroid hormone parameters 
during gestation and the occurrence of CTS symptoms. Secondly, we investigated whether the 
relationship between thyroid function and CTS symptoms was independent of fluid retention. 
METHODS
Participants
From January 2013 to September 2014, pregnant women who had their first antenatal ap-
pointment at one of the 17 participating community midwife offices in the southeast of the 
Netherlands were invited for thyroid function screening as part of the Holistic Approach to 
Pregnancy and the first Postpartum Year (HAPPY) study, the design of which has been described 
in detail elsewhere.16 In general, 86% of pregnant women in the Netherlands register at com-
munity midwife offices, the other 14% start antenatal care in a hospital.17 During the 20 months 
of inclusion, about 4,150 women visited the participating midwife offices. Since most outcomes 
were assessed using questionnaires, only Dutch-speaking Caucasian women (N = 3,475) were 
invited to participate, in order to avoid language problems. Moreover, the following NHANES 
(National Health and Nutrition Examination Survey)18 exclusion criteria were used: a known 
history of previous thyroid dysfunction (Hashimoto thyroiditis or Graves’ disease, either on 
hormone replacement therapy or not); a known history of autoimmune disease (e.g. diabetes-I, 
rheumatoid arthritis); and the use of drugs that might interfere with thyroid function (e.g. use 
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of lithium in bipolar patients). Women with multiple pregnancies, women using psychotropic 
drugs, or women with a diagnosis of severe mental illness were also excluded. This resulted 
in 3,159 eligible women of whom 2,275 (response rate = 72%) agreed to participate. Of these 
women, complete data up until the first postpartum week were available for 1,269 women. This 
sample size is large enough to evaluate the research questions with sufficient statistical power. 
Characteristics of the sample population are presented in Table 1. 
Standard Protocol Approvals, Registrations and Patient Consents
The study was approved by the Medical Ethical Committee of the Máxima Medical Center, 
Veldhoven and the Psychological Ethics Committee of Tilburg University (protocol number EC-
2012.25). All participants signed a written informed consent form. 
Table 1 Characteristics of the 1,269 pregnant women included in the study.
Total (N = 1,269) CTS (+) (n = 452) CTS (-) (n = 817) p
Mean (SD) n (%) Mean (SD) n (%) Mean (SD) n (%)  t  χ2
 Demographic features
age (in years) 30.4 (3.5) 30.3 (3.7) 30.5 (3.4) .147
Educational level
Low 414 (32.6) 172 (38.1) 242 (29.6) .002
Higha 855 (67.4) 280 (61.9) 575 (70.4)
Marital status
With partner 1257 (99.1) 449 (99.3) 808 (98.9) .440
Obstetric features
Parity
Primiparous 632 (49.8) 249 (55.1) 383 (46.9) .005
Previous abortion or miscarriage 321 (25.3) 103 (22.8) 218 (26.7) .126
Unplanned pregnancy 65 (5.1) 26 (5.8) 39 (4.8) .449
Lifestyle habits during pregnancy
Smoking 47 (3.7) 17 (3.8) 30 (3.7) .936
alcohol intake 43 (3.4) 14 (3.1) 29 (3.5) .670
bMI pre-pregnancy 23.8 (3.9) 24.6 (4.0) 23.4 (3.7) <.001*
Somatic complaints
Mean fluid retention score 
(range 0-8)b
1.1 (1.1)  1.6 (1.4) 0.8 (0.9) <.001*
Psychological well-being
  EDS score 4.7 (3.4)   5.2 (3.6)   4.4 (3.4)   <.001* 
a Bachelor or Master’s degree b Mean of the four time points *significance level p <.05
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At 32 weeks’ gestation, women were asked for the three key symptoms of CTS during the previ-
ous weeks: “Did you suffer any of the following symptoms during the last trimester of pregnancy: 
pain, tingling sensations or numbness in hands or wrists? Yes / no”. Subsequently, the positive 
cases completed the Boston Carpal Tunnel Questionnaire (BCTQ) to evaluate the severity of 
symptoms and functional impairment. The BCTQ consists of two different scales measuring 
symptom severity (11 items) and functional status (8 items) on a five-point Likert scale.19,20 Both 
scales result in mean scores between 1 and 5, where greater symptom severity or functional 
impairment is represented by higher scores. The total BCTQ score was calculated as the mean 
of all the items. The BCTQ has been validated in the Netherlands.21 At the end of the first week 
postpartum the BCTQ was also used to evaluate the occurrence of symptoms during the last 
weeks of pregnancy. 
Biological assays
Thyroid stimulating hormone (TSH), free thyroxine (FT4) and Thyroperoxidase antibodies (TPO-
Abs) were determined at 12 and 32 weeks’ gestation in Li-heparin plasma using electrochemo-
luminescence assays (Cobas® e 601, Roche Diagnostics, Mannheim Germany). The non-pregnant 
reference ranges of TSH are 0.40-4.0 mU/L, of FT4 10.0-24.0 pmol/L and of TPO-Abs <35 IU/L. 
Covariates
Depression
Depression has been associated with heightened pain experience,22 also in pregnant women.23 
Therefore, when assessing CTS symptoms during pregnancy, it is important to adjust for de-
pression. The Dutch version of the Edinburgh Depression Scale (EDS)24 was used to measure 
symptoms of depression at 12, 22 and 32 weeks’ gestation. The EDS consists of ten items and 
has been validated in the Netherlands among the pregnancy trimesters.25 The total score ranges 
from 0 to 30, with higher scores indicating more symptoms of depression. The EDS has shown to 
be a reliable instrument to detect women with syndromal depression.25 
Assessment of fluid retention and pain
At 12, 22 and 32 weeks’ gestation and during the first postpartum week regarding the last weeks 
of pregnancy, the participants completed a questionnaire containing a variety of complaints 
which are generally mentioned during gestation, including questions related to fluid retention. 
The items were scored on a five-point Likert scale ranging from not at all (0) to very severe (4). 
The sum scores on the items “fluid retention in hands and/or feet” and “fluid retention in general” 
were used to create a two-item subscale on fluid retention with a range of 0-8. In order to control 
for pain-related reporting bias in women with CTS symptoms, thyroid hormone levels were com-
pared between women who suffered from another frequently reported pain symptom during 
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gestation (headache) and women who did not. Moreover, at 12 weeks’ gestation, the participat-
ing pregnant women completed a questionnaire to assess baseline characteristics (demograph-
ics, lifestyle habits including BMI, smoking habits and alcohol intake, and current and previous 
obstetric characteristics). Information about parity was obtained from the obstetric records.
Statistical analyses
Data are presented as mean (SD) or number of participants (n) and percentages. We performed 
t-tests comparing the means (SD) between CTS + and CTS - women for continuous variables and 
χ2-tests for categorical variables. FT4 values were normally distributed, but TSH values were not. 
Therefore, TSH values were log transformed. The effect sizes of significant differences between 
groups were evaluated according using Cohen’s d for t-tests and Cramer’s V for χ2-tests.26 For 
Cohen’s d, .2, .5 and .8 are considered small, medium and large effect sizes, respectively. For 
Cramer’s V, .1, .3 and .5 are considered small, medium and large effect sizes, respectively, for df 
= 1, and .06, .17 and .29, respectively, for df = 3. Single logistic regression analyses were used to 
investigate the relationship between the different thyroid parameters and CTS symptoms. We 
checked for a non-linear effect, which was not found. We calculated FT4 quartiles at 32 weeks’ 
gestation and performed repeated measures ANOVA comparing mean scores of fluid retention 
symptoms between different quartiles, adjusting for parity, age, BMI and depression scores with 
Bonferroni correction for multiple testing. Finally, a multiple logistic regression analysis was 
performed, with CTS +/- as the dependent variable and FT4 levels as independent continuous 
variables, adjusted for fluid retention scores (grand mean of four time points), depression (EDS 
scores), age, parity and BMI. A p-value <.05 was considered significant. Statistical analyses were 
performed using the Statistical Package of Social Science (SPSS, 21.0).
RESULTS
Baseline data were available for 2,221 women and complete data up until the first postpartum 
week were available of 1,269 women. We compared baseline characteristics between women 
with (n = 952) and without (n = 1,269) missing data at one week postpartum. Women with 
missing data were less high educated (57% vs. 67%, χ2 (1, N = 2,125) = 25.7, p <.001, V = .11) and 
less often had a partner (98% vs. 99%, χ2 (1, N = 2,133) = 5.64, p = .018, V = .05). Age and parity 
did not differ between women with and without missing data. 
In the present study, 452 of 1,269 women (36%) reported at least one of the three key symptoms 
of carpal tunnel syndrome during pregnancy. Of these 452 cases, 140 (23%) cases reported 
unilateral and 312 (69%) bilateral CTS symptoms. As shown in Table 1, women who reported CTS 
symptoms were more often primiparous (p = .005, V = .08), lower educated (p = .002, V = .09) and 
had significantly higher mean scores on fluid retention (p <.001, d = .68), higher BMI (p <.001, d 
= .31) and higher levels of depressive symptoms (p <.001, d = .23). 
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association between thyroid hormone and carpal tunnel syndrome 
symptoms
Single logistic regression analyses results of thyroid fuction parameters and CTS are shown in 
Table 2. Women with higher mean FT4 levels at 12 and 32 weeks had a significantly lower likeli-
hood of having CTS symptoms (OR = 0.93, 95% CI [0.88-0.99] and OR = 0.80, 95% CI [0.73-0.87], 
respectively). Because the effect size at 12 weeks was low and CTS mostly occurs later in preg-
nancy, FT4 levels at 32 weeks were used for further analyses. Within the groups of women with 
CTS symptoms, FT4 levels at 32 weeks did not relate to unilateral or bilateral symptoms (data not 
shown). For comparison purposes, we also examined associations between thyroid hormone 
levels and a non-CTS pain symptom (headache) and found no differences in FT4 levels between 
women with (n = 491) and without (n = 778) headache symptoms (OR = 0.95, 95% CI [0.87-1.03]).
To further assess the relation between FT4 and CTS, the FT4 levels at 32 weeks’ gestation were 
divided in quartiles (<10.86 pmol/L, 10.86-11.77 pmol/L, 11.78-12.68 pmol/L and >12.68 pmol/L, 
respectively). The percentage of women reporting CTS per FT4 quartile is presented in Figure 1. 
Women with FT4 levels in the lowest quartile reported significantly more often CTS symptoms 
(χ2 (3, N = 1,269) = 30.9, p <.001). 
In Figure 2, mean scores on the fluid retention subscale during pregnancy of pregnant women in 
relation to FT4 quartiles at 32 weeks are presented, adjusted for BMI, age, parity and depression 
scores. Repeated measures ANOVA showed that the lower the quartile of FT4, the higher the 
scores of fluid retention during gestation (F3,1261 = 20.5, p <.001 after Bonferroni correction).
To examine whether the association between FT4 and CTS was independent of fluid retention 
and depressive symptoms, a multiple logistic regression analysis was performed with CTS +/- as 
dependent variable and FT4 levels at 32 weeks as independent continuous variable, adjusted 
for fluid retention, depressive symptoms, BMI, parity and age. The results are presented in Table 
3. FT4 (OR = 0.88, 95% CI [0.80-0.97]), higher fluid retention scores throughout pregnancy (OR = 
1.78, 95% CI [1.57-2.02]) and higher EDS scores (OR = 1.05, 95% CI [1.01-1.09]) were significantly 
related to CTS, whereas other variables were not.
Table 2 Single logistic regression analyses in 1,269 pregnant women with CTS +/- as dependent variable and differ-




TPO-abs >35 IU/l at 12 weeks 0.90 0.59 1.36 .604
FT4 at 12 weeks pmol/L 0.93 0.88 0.99 .038*
logTSH at 12 weeks 1.26 0.90 1.78 .184
FT4 32 at weeks (pmol/L) 0.80 0.73 0.87 <.001*
logTSH at 32 weeks 1.13 0.69 1.86 .635
*significance level p <.05
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Finally, within the group of women who reported CTS (n = 452), the intensity of CTS symptoms 
(mean of total BCTQ scores at 32 weeks and during the last weeks of pregnancy) was correlated 
with thyroid hormone levels at week 32 and mean fluid retention scores. Women with higher 
symptoms intensity also reported higher mean levels of fluid retention (rs = 0.46, p <.001, me-
dium to large effect size according to Cohen26) and had lower FT4 levels at 32 weeks’ gestation 
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Quartiles FT4 at 32 weeks gestation
Figure 1 Percentage of women with CTS during pregnancy presented per quartile FT4 at 32 weeks’ gestation. χ2 (3, 














Mean fluid retention score
Figure 2 Relation between the symptom “fluid retention’’ at four time points during pregnancy and FT4 quartiles at 
32 weeks’ gestation, adjusted for age, parity, BMI and depression. 
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DISCUSSION
This study showed that women with FT4 levels in the lower quartiles reported CTS symptoms 
significantly more often than women with higher FT4 levels. Women with lower FT4 levels also 
reported significantly higher levels of fluid retention during gestation, adjusted for BMI, age, 
parity and depression. However, fluid retention did not account for the observed association 
between low thyroid levels and CTS. 
CTS is a highly prevalent (30%) condition among hypothyroid patients.11,13 The underlying 
physiological mechanism remains unclear. It has been hypothesized that a combination of 
compression and physiological changes of the median nerve lead to the typical CTS symptoms 
in hypothyroid patients27 but evidence is still lacking. To date, a possible relationship between 
CTS and thyroid function during pregnancy has never been investigated. It is known, however, 
that FT4 levels decrease during gestation, partly because the substantial increase of extracellular 
volume, partly because of the increasing fetal demands of maternal FT4.15 We previously showed 
a significant relation between inappropriate weight gain and lower FT4 levels during gestation.28 
It is not clear yet whether this increase is related to the possible metabolic effect of lower FT4 
or to a possible effect of FT4 on fluid retention. In the current study, we showed that lower 
FT4 levels are related to a higher prevalence of CTS. Self-reported symptoms of fluid retention 
increased with increasing term (Figure 2), which is a normal physiological phenomenon during 
pregnancy. In the last trimester, the increase in weight can mostly be attributed to an increase 
in extravascular fluid.29 This explains why CTS symptoms most commonly present at a later stage 
during pregnancy.9 We also found that lower levels of FT4 were significantly related to higher 
levels of self-reported fluid retention symptoms. Moreover, within the group of women with 
CTS symptoms, higher levels of fluid retention were significantly related to higher levels of CTS 
symptom severity and functional impairment. Current theories about the pathophysiology of 
entrapment neuropathies are mainly based on experimental (animal) studies.30 The biologic 
response to compression seems to be a cascade comprising endoneurial edema, demyelination, 




Higher FT4 at 32 weeks of gestation 0.88 0.80 0.97 .005*
Higher fluid retention score during pregnancy 1.78 1.57 2.02 <.001*
Higher bMI pre-pregnancy 1.03 1.00 1.06 .088
Multiparity 0.80 0.61 1.03 .086
Higher age 0.99 0.96 1.03 .705
Higher EDS score 1.05 1.01 1.09 .010*
*significance level p <.05
Chapter 3
46
inflammation, distal axonal degeneration, fibrosis, growth of new axons, remyelination and 
thickening of the perineurium and endothelium.30,31 However, the pathophysiological effect of 
fluid retention on the median nerve as occurs in pregnancy is unclear. Fluid retention in the 
synovial tissue in the carpal tunnel may lead to pressure on the median nerve. On the other 
hand, fluid retention can also cause endoneurial edema and thickening of the perineurium caus-
ing the nerve itself to enlarge or result in metabolic changes in the nerve, resulting in impaired 
nerve function without nerve enlargement.32 To distinguish between these mechanisms, further 
studies should focus on the use of ultrasonography of the carpal tunnel, which is non-invasive 
and therefore suitable for pregnant women.33 
Reported symptoms, such as tingling, paresthesia and pain in particular, are a complex, con-
scious, unpleasant somatic experience with cognitive, emotional and sensory features.34 This 
subjective experience can be influenced by mood and emotional state. Psychological variables 
are increasingly important in explaining models of reporting somatic symptoms.35 There is 
abundant evidence in the literature for the significant impact of cognitive and affective vari-
ables on pain experience.22,35 Depression, for example, has been associated with heightened 
pain experience,22 also in pregnant women.23 Therefore, when assessing CTS symptoms during 
pregnancy, it is important to adjust for the emotional status, especially depression. Multivariable 
analyses showed that the observed inverse association between FT4 levels and CTS was affected 
by depressed mood.
This study has several strengths, including the prospective longitudinal design with repeated 
measurements, the adjustment for comorbid depressive symptoms and the large sample size. 
One of the limitations is that CTS was not diagnosed either clinically or using electrodiagnostic 
tests (EDT). However, the diagnosis of CTS in general is based on patient-reported key symptoms: 
pain, tingling sensations or numbness in hands or wrists.9,36,37 Clinical tests of CTS (Tinel and 
Phalen) have poor predictive value of accurately diagnosing CTS.38 Moreover, it has repeatedly 
been demonstrated that the diagnostic validity of reporting these key symptoms is similar to 
electrodiagnostic techniques.37 A questionnaire referring to the most typical CTS symptoms has 
a similar sensitivity, specificity and positive predictive value as EDT.39 EDT is relatively invasive and 
time-consuming; the use of a questionnaire is therefore an appropriate alternative for pregnant 
women. Another limitation is the generalizability of the results; only white Caucasian women 
were included and the educational level was relatively high. Moreover, of the 2,221 women with 
baseline data, 1,269 women with complete data up to one week postpartum were included in 
the analyses. Women with and without missing data significantly differed based on education 
and marital status, though effect sizes were small, suggesting little if any clinical relevance. The 
missing data at one week postpartum were mostly due to practical reasons because midwives 
did not always inform in time when a woman gave birth. Missing data were therefore mostly at 
random, decreasing the likelihood of bias. Furthermore, the design of this study was prospective, 
with repeated measurements of CTS and thyroid function during pregnancy. However, the stron-
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gest associations were found at the end of pregnancy (at 32 weeks), and these cross-sectional 
associations do not allow conclusions about causal inference.
In conclusion, lower levels of free T4 are related to a higher prevalence of CTS and higher levels of 
fluid retention. The results of this study contribute to the understanding of possible mechanisms 
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Carpal tunnel syndrome symptoms 
during late pregnancy may negatively 
affect breastfeeding initiation





Objective: To investigate the relation between carpal tunnel syndrome (CTS) symptoms and the 
initiation of breastfeeding. 
Design: A prospective longitudinal cohort study with inclusion period from January 2013 till 
September 2014. 
Setting: Dutch women who had their first antenatal visit at one of 17 participating community 
midwife offices in the Netherlands were included in this project. 
Participants: A sample of 1,530 pregnant women who were followed up until the first postpar-
tum week.
Measurements: Boston Carpal Tunnel Questionnaire to assess the severity of CTS symptoms. 
Findings: 1,121 of 1,530 women (73%) initiated breastfeeding their newborn and 423 of 1,530 
women (28%) reported CTS symptoms during their last weeks of pregnancy. There was no dif-
ference in the prevalence of CTS between women who did or did not initiate breastfeeding. 
Within the group of women with CTS, mild CTS symptoms (OR = 1.93, 95% CI [1.10-3.36]), higher 
education (OR = 2.10, 95% CI [1.34-3.29]) and multiparity (OR = 0.61, 95% CI [0.38-0.97]) were 
independently related to breastfeeding initiation.
Key conclusions: Women with mild CTS symptoms seem to be more likely to initiate breast-
feeding compared to women with more severe CTS symptoms.
Implications for practice: Midwives and obstetricians should ask for the presence of CTS symp-
toms and could offer women non-invasive treatment for symptom relief.
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INTRODUCTION
Breastfeeding is the preferred form of feeding for newborns: the World Health Organization rec-
ommends exclusive breastfeeding during the first six months of the infant’s life.1 In 2001, 75% of 
mothers started to breastfeed their newborns in the US.2 In 2011, this number increased to 79%.3 
In the Netherlands, around 75% of mothers initiate breastfeeding their infant.4,5 Characteristics 
that have been related to the initiation of breastfeeding are higher education, not smoking and 
primiparity.4-7 There is some evidence that women who delivered at home are more likely to 
initiate breastfeeding.5 Previous studies report contradictory results on the effect of mode of 
delivery on breastfeeding. Leung et al.6 state cesarean delivery as a risk factor for not initiating 
breastfeeding, while Patel et al.8 did not find this relation. Moreover, spontaneous labor may 
increase the likelihood of breastfeeding initiation. Women who do not go into spontaneous 
labor often receive synthetic oxytocin, which desensitizes the oxytocin receptors and therefore 
negatively affects milk production and ejection.9,10 The effect of gestational depression on breast-
feeding is also unclear. Some studies suggest that women who are depressed are less likely to 
initiate breastfeeding,11,12 while others report a relation between depression and breastfeeding 
intention13 or duration,14 but not initiation. 
Carpal tunnel syndrome (CTS) is a very common musculoskeletal condition during pregnancy.15 
Typical symptoms are tingling, paresthesia and pain in the hand, as a consequence of the com-
pression of the median nerve at the level of the carpal tunnel.16,17 CTS is much more common 
in pregnant women compared to the non-pregnant female population.18,19 CTS often presents 
in the later stages of pregnancy, specifically during the third trimester.18,20-22 Symptom sever-
ity reduces rapidly in the first postpartum week,15,21 but up to 30% of women report symptom 
persistence three years after delivery.19,23
Symptoms of CTS may interfere with a woman’s decision to initiate breastfeeding. The sensory 
problems in the fingers may challenge women during breastfeeding, especially during the night 
time feedings when symptoms are typically worse. Even though the prevalence of CTS among 
pregnant women is high, the possible impact on the initiation of breastfeeding has never been 
investigated. Therefore, the aim of the current study is to investigate whether the prevalence 
or severity of CTS symptoms is related to the initiation of breastfeeding. We hypothesize that 
women with more severe CTS symptoms are less likely to initiate breastfeeding. 
METHODS
Participants
This study is part of the Holistic Approach to Pregnancy and the first Postpartum Year (HAPPY) 
study (described in detail elsewhere24). Pregnant women who had their first antenatal visit 
between January 2013 and September 2014 at one of the 17 participating community midwife 
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practices in the southeast of the Netherlands were invited to participate in the study. In general, 
85% of pregnant women in the Netherlands register at community midwife offices, the other 
15% start antenatal care in a hospital.25 During the 20 months of inclusion, about 4,150 women 
visited the participating midwife offices. Since most outcomes were assessed using question-
naires, only Dutch-speaking Caucasian women (N = 3,475) were invited to participate, in order to 
avoid language problems. Women with multiple pregnancies, thyroid dysfunction, autoimmune 
disease, women using psychotropic drugs and with a diagnosis of severe mental illness were 
excluded. This resulted in 3,159 eligible women of whom 2,275 (response rate = 72%) signed a 
written informed consent to participate. Only women who delivered at term (≥37 weeks’ gesta-
tion) were included in the current study’s analyses (n = 1,530). This sample size is large enough 
to evaluate the research questions with sufficient epidemiologic power. Characteristics of the 
sample population are presented in Table 1. The study was approved by the Psychology Ethics 
Committee of Tilburg University (protocol number EC-2012.25) and additionally evaluated by 
the Medical Ethical Committee of the Máxima Medical Center in Veldhoven. 
Procedure
Women completed questionnaires at 12, 22 and 32 weeks’ gestation and one week postpartum. 
One week postpartum, women were asked how they were currently feeding their baby. Women 
who were exclusively breastfeeding, who started breastfeeding but had stopped and women 
who combined breastfeeding and bottle feeding were considered to have initiated breastfeeding. 
CTS assessment
During the first postpartum week, women were asked for the three key symptoms of CTS during 
the last weeks of pregnancy: “Did you suffer any of the following symptoms during pregnancy: 
pain, tingling sensations or numbness in hands or wrists? Yes / no”. Subsequently, the positive 
cases completed the Boston Carpal Tunnel Questionnaire (BCTQ) to evaluate the severity of 
symptoms and functional impairment. The BCTQ consists of two different scales: the Symptom 
Severity Scale (SSS; 11 items) and the Functional Status Scale (FSS; 8 items). The items are scores 
on a five-point Likert scale.26,27 The total score on the two subscales is calculated by averaging 
the scores on all individual items. Higher scores on the two subscales reflected more severe 
symptoms and more functional impairment and there is no cut-off score. The BCTQ has been 
validated in the Netherlands.28 
Covariates
Baseline variables were collected at 12 weeks’ gestation (BMI pre-pregnancy, education, smok-
ing behavior, etc.). Obstetric data (birth weight, parity, home birth, spontaneous labor) were 
obtained from the obstetric records. 
The Dutch version of the Edinburgh Depression Scale (EDS)29 was used to measure symptoms of 
depression at 12, 22 and 32 weeks. The EDS consists of ten items and has been validated in the 
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Netherlands among the pregnancy trimesters.30 The total score ranges from 0 to 30, with higher 
scores indicating more severe symptoms of depression. The EDS has shown to be a reliable 
instrument to detect women with syndromal depression.30 We computed a grand mean score of 
the EDS of the scores on the three different time points. 
Statistical analyses
Statistical analyses were performed using the Statistical Package of Social Science (SPSS, 22.0). 
Data are presented as mean (SD) or percentages. We performed t-tests comparing the means 
(SD) between breastfeeding initiation yes/no for continuous variables and χ2-tests for categorical 
variables. The effect sizes of significant differences between groups were evaluated according 
using Cohen’s d for t-tests and Cramer’s V for χ2-tests.31 For Cohen’s d, .2, .5 and .8 are considered 
small, medium and large effect sizes, respectively. For Cramer’s V, .1, .3 and .5 are considered 
small, medium and large effect sizes, respectively, for df = 1. Within the group of women with 
CTS symptoms, multiple logistic regression analysis was performed, with breastfeeding initiation 
(yes/no) as the dependent variable and mild CTS symptoms as independent variable, adjusted 
for BMI, educational level, smoking, parity, home birth, spontaneous labor and depressive symp-
toms during pregnancy.
FINDINGS
Baseline data were available for 2,221 women and complete data up until the first postpartum 
week were available of 1,563 women. We compared baseline characteristics between women 
with (n = 658) and without (n = 1,563) missing data at one week postpartum. Women with 
missing data were younger (30.0 vs. 30.5, t = 2.66, p = .008, d = .13), less high educated (52% vs. 
67%, χ2 (1, N = 2,125) = 40.1, p <.001, V = .14) and less often had a partner (97% vs. 99%, χ2 (1, N 
= 2,133) = 15.8, p <.001, V = .09). Parity did not differ between women with and without missing 
data. Although the differences between completers and drop-out were statistically significant 
(due to the large sample sizes), the effect sizes were rather low, suggesting little if any clinical 
relevance. Only women who delivered at term (≥37 weeks’ gestation) were included in further 
analyses (n = 1,530).
In the present study, 1,121 of 1,530 women (73%) initiated breastfeeding and 423 of 1,530 
women (28%) reported CTS symptoms during their last weeks of pregnancy, with a mean BCTQ 
score of 1.70 (0.62), mean SSS score of 1.92 (0.68) and mean FSS score of 1.49 (0.64). There was 
no statistically significant difference between the prevalence of CTS during the last weeks of 
pregnancy among women who initiated breastfeeding compared to women who did not (Table 
1). Women who initiated breastfeeding were more often higher educated (χ2 (1, N = 1,530) = 
61.2, p <.001, V = .20), primiparous (χ2 (1, N = 1,530) = 13.9, p <.001, V = .10), non-smokers (χ2 (1, 
N = 1,530) = 12.9, p <.001, V = .09) and more often gave birth at home (χ2 (1, N = 1,530) = 9.61, 
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p = .002, V = .08) (Table1). Women who initiated breastfeeding also had lower BMIs (t = 3.73, p 
<.001, d = .20). 
We subsequently looked within the group of women who reported CTS symptoms (n = 423). 
There were significantly more primiparous women in the CTS group compared to the group 
of women without CTS (57% vs. 46%, respectively, χ2 (1, N = 1,530) = 16.9, p <.001, V = .11). 
Moreover, women with CTS less often gave birth at home (12% vs. 16%, χ2 (1, N = 1,530) = 3.90, p 
= .048, V = .05), less often had spontaneous labor (76% vs. 82%, χ2 (1, N = 1,530) = 7.77, p = .005, 
V = .07) and had a higher BMI (24.6 vs. 23.5, t = 4.96, p <.001, d = .28). The other characteristics 
as presented in Table 1 were similar in this CTS subgroup (data not shown). Within the group 
who reported CTS symptoms, different quartiles were calculated according to symptom severity 
scores, with higher quartiles reflecting more severe symptoms. As can be seen in Figure 1, in 
the group of women with symptom severity scores in the lowest quartile, up to 79% initiated 
breastfeeding while in the other quartiles this figure was between 64 and 69% (χ2 (3, n = 423) 
= 6.34, p = .096). There is a clear difference in breastfeeding initiation rate between the lowest 
quartile and the upper three quartiles. Therefore, based on Figure 1, mild CTS symptoms was 
defined using the 25th percentile (SSS score = 1.38) as cut-off. 
Finally, a multiple logistic regression analysis was performed with breastfeeding initiation yes/
no as dependent variable and mild CTS symptoms as independent variable, adjusting for BMI, 
educational level, smoking, parity, home birth, spontaneous labor and depressive symptoms 
Figure 1 Percentage of women with carpal tunnel syndrome (CTS) who initiated breastfeeding presented per quar-
tile mean Symptom Severity Scale (SSS) score. χ2 (3, n = 423) = 6.34, p = .096.
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during pregnancy. The results are presented in Table 2. Mild CTS symptoms (OR = 1.93, 95% CI 
[1.10-3.36]), higher education (OR = 2.10, 95% CI [1.34-3.29]) and multiparity (OR = 0.61, 95% 
CI [0.38-0.97]) were independently related to breastfeeding initiation. When we repeated the 
multiple regression analysis with the SSS as a continuous variable similar results were found 
(data not shown). Moreover, similar analyses with the FSS did not lead to significant results (data 
not shown).
DISCUSSION
In the current study, 73% of the women initiated breastfeeding and 28% reported CTS symp-
toms during their last weeks of pregnancy. The prevalence of breastfeeding initiation was not 
significantly different between women with or without CTS symptoms. However, within the 
group of women who reported CTS, women with mild CTS symptoms were more likely to initi-
ate breastfeeding. 
In 2013, 75% of women in the Netherlands initiated breastfeeding their newborn,25 compared 
to 73% in our study. Breastfeeding initiation rates vary greatly across Europe, with over 95% in 
Norway32 and about 55% in Ireland.33 Compared to the US, breastfeeding initiation rates are 
similar in the Netherlands.3
The prevalence of CTS symptoms in our sample of pregnant women (28%) is lower compared to 
the 35% we have previously reported.18 In this earlier study, we looked at CTS symptoms during 
the whole pregnancy, but in the current study only the last weeks of pregnancy were taken into 
account. We believe that symptoms earlier on in pregnancy which disappear during the last 
weeks of pregnancy are unlikely to influence the initiation of breastfeeding due to functional 
hand problems. Breastfeeding initiation rates were not lower among women who reported CTS 
symptoms. As we have previously shown, symptom severity and functional impairment is rela-
Table 2 Multiple logistic regression analysis with initation of breastfeeding as dependent variable within 423 women 




Mild CTS symptomsa 1.93 1.10 3.36 .021*
High educationb 2.10 1.34 3.29 .001*
Higher bMI 1.00 0.95 1.05 .918
Smoking 0.41 0.14 1.20 .106
Multiparity 0.61 0.38 0.97 .035*
Home birth 1.99 0.92 4.30 .079
Spontaneous labor 0.92 0.54 1.57 .759
Higher EDS score 1.02 0.96 1.09 .574
a cut-off CTS symptoms <25th percentile (mean BCTQ <1.38) b Bachelor or Master’s degree *significance level p <.05
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tively mild in the pregnant population.18 In the current literature there are no pregnancy-specific 
cut-off scores for the severity of CTS. In our study, the 25th percentile of the SSS score was used 
as a cut-off point reflecting mild scores, and women with lower SSS scores were more likely to 
initiate breastfeeding. 
The likelihood of breastfeeding was higher in women with higher educational level, and women 
who breastfed less often smoked, had a lower BMI, were more often primiparous and more often 
gave birth at home, which corresponds to results of previous studies.4-7 The mean score on the 
EDS was 4.7, which corresponds to the mean score (4.5) of another sample of Dutch pregnant 
women of Bergink et al.30 In the current study, the mean EDS score during pregnancy did not 
differ between women who initiated breastfeeding and women who exclusively bottle fed their 
newborn. The results are in agreement with the studies from Dias et al.14 and Fairlie et al.13, who 
conclude that depressive symptoms do not influence breastfeeding initiation. Mathews et al.12 
did find a relation between depressive symptoms during pregnancy and breastfeeding initia-
tion, but they only included primiparous women in their study. 
Spontaneous labor did not affect breastfeeding initiation in the current study. Home birth was 
associated with breastfeeding initiation in the study by Lanting et al.5 but not in the current study 
at a multivariate level. Before 2005, however, the prevalence of home births was higher (30%)5 
compared to the current study (15%): recent annual figures of home birth in the Netherlands 
vary between 5-15% (with lower home births in large cities) and are declining gradually over the 
last decade.25
This study has several strengths, including the prospective design, the large sample size and 
the adjustment for several possible important determinants of breastfeeding initiation (edu-
cational level, parity and depression). Characteristics of the current study sample are similar to 
the general pregnant population in the Netherlands, based on age, parity and breastfeeding 
initiation rates.25 Several limitations of the current study need to be mentioned. First, CTS was 
not diagnosed either clinically or using electrodiagnostic tests (EDT). However, the diagnosis 
of CTS in general is based on patient-reported key symptoms: pain, tingling sensations or 
numbness in hands or wrists.18,34,35 Clinical tests of CTS (Tinel and Phalen) have poor predictive 
value of accurately diagnosing CTS.36 Another limitation is the generalizability of the results. 
First, of the 2,221 women with baseline data, 1,563 women with complete data up to one week 
postpartum were included in the analyses. Women with and without missing data significantly 
differed based on age, education and marital status, though effect sizes were small. The miss-
ing data at one week postpartum was mostly due to practical reasons because midwives did 
not always inform us in time when a woman gave birth. Missing data was therefore mostly at 
random, decreasing the likelihood of bias. Secondly, only Caucasian women were included and 
the educational level was relatively high; 65% of the women in the current study were highly 
educated compared to 52% of the general Dutch female population of similar age.37 However, 
the southeast of Brabant, where recruitment took place, is a relatively highly educated region in 
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the Netherlands. Moreover, non-Caucasian women were not included in the study, and they are 
generally less high educated.38 
CTS affects at least one in four pregnant women during late pregnancy. In general, CTS during 
pregnancy is underdiagnosed: women often do not report complaints and health professionals 
do not ask for them.39 Since severe CTS symptoms might interfere with a woman’s decision 
to start breastfeeding, it is important for health professionals to recognize the problem. CTS 
symptoms can easily be treated conservatively.40 Women can wear a wrist splint at night, which 
stabilizes the wrist in a neutral position, reducing pressure on the median nerve.20 In four out 
of five women, a wrist splint is effective in reducing the CTS symptoms.15 Steroid injections in 
the carpal tunnel can also provide symptom relief,20 but is often not the preferred intervention 
for pregnant women. Since CTS symptoms mostly disappear in the weeks following delivery,19 
surgery is hardly ever performed during pregnancy.40 Another non-invasive and patient-friendly 
treatment for CTS is currently under research: traction and rotation to the wrist using a mechani-
cal traction device (described in detail elsewhere41). If proven effective, health care professionals 
will have another non-invasive treatment especially suitable for pregnant women with CTS.
In conclusion, women with mild CTS symptoms seem to be more likely to initiate breastfeeding 
compared to women with more severe CTS symptoms. Midwives and obstetricians should ask 
for the presence of CTS symptoms and could offer women non-invasive treatment for symptom 
relief.
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Follow-up of pregnancy-related carpal tunnel 
syndrome symptoms at 12 months postpartum: 
a prospective study





Objective: To study the persistence and predictors of pregnancy-related carpal tunnel syndrome 
(CTS) symptoms in the first postpartum year.
Design: A prospective longitudinal cohort study. 
Setting: Dutch women who became pregnant between January 2013 and September 2014 in 
the southeast of the Netherlands and who were followed until 12 months postpartum. 
Population or Sample: A total of 1,044 Dutch pregnant women.
Methods: The prevalence of CTS symptoms was assessed during the last trimester of pregnancy. 
In the positive cases, the severity of CTS was assessed using the Boston Carpal Tunnel Question-
naire (BCTQ). Subsequently, the persistence of CTS symptoms was evaluated until 12 months 
postpartum. 
Main Outcome Measures: Persistence and predictors of CTS symptoms during postpartum. 
Results: Of the 1,044 women, 354 (34%) reported CTS symptoms during pregnancy. Of these 
354 cases, 54 (15%) still reported these key symptoms at 12 months postpartum. Within these 
354 women, early onset of CTS symptoms during pregnancy (OR = 2.88, 95% CI [1.45-5.72]), 
higher severity of CTS during the last trimester (OR = 1.93, 95% CI [1.08-3.45]) and higher mean 
depression scores on the Edinburgh Depression Scale (EDS) postpartum (OR = 1.11, 95% CI [1.03-
1.19]) were significantly related to the persistence of CTS at 12 months postpartum. 
Conclusions: One third of pregnant women report CTS symptoms of whom 15% (5% of the total 
pregnant population) still complain of CTS at 12 months follow-up. Early onset of CTS symptoms 
during pregnancy and higher severity of symptoms during the last trimester as well as depres-
sive symptoms during postpartum are independently related to long-lasting CTS symptoms. 
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INTRODUCTION 
Carpal tunnel syndrome (CTS) is a common condition among pregnant women. We found a 
prevalence of 34% during the last trimester in a large cohort of pregnant women.1 Severity 
of CTS symptoms generally decreases quickly after childbirth2 and symptoms are believed to 
resolve completely in the postpartum period.3 In some women, however, symptoms may persist 
in the postpartum period. Only few studies have investigated persisting pregnancy-related CTS 
symptoms in the postpartum period and they report a great variation in persisting symptoms. 
According to the current literature, 4% to 54% of women with CTS symptoms during pregnancy 
still report symptoms at one year postpartum4,5, and 30% at three years.3 This wide range is 
mainly to be explained by methodological flaws. The studies had small sample sizes including 
only 37 to 46 women with CTS symptoms during pregnancy. One study3 only included women 
with an electrophysiologically confirmed diagnosis of CTS but electrodiagnostic tests can lead 
to false negative results.6 Insight into possible predictors of long-lasting CTS symptoms is even 
scarcer. Padua et al.4 found that earlier onset of symptoms during pregnancy was a predictive 
factor for persistent CTS symptoms at follow-up. 
It is reasonable to suggest that severity of CTS symptoms during pregnancy might also pre-
dict the long-lasting persistence of CTS postpartum, but evidence to support this hypothesis 
is lacking. Another possible predictor which needs to be considered when assessing sensory 
symptoms, but has never been reported, is emotional status during postpartum, including post-
partum depression. Pain is a subjective experience which can largely be influenced by emotional 
distress such as depression,7 also in pregnant women.8 In a recent meta-analysis, people with 
chronic pain (>3 months) reported more problems in several psychological domains, including 
depression, compared to healthy control.9 Depression was also a predictor of symptom severity 
in CTS patients.10,11 Therefore, when assessing CTS symptoms during pregnancy and postpartum, 
it is important to adjust for depression.
The primary aim of the present prospective study was to investigate the persistence of preg-
nancy-related CTS symptoms in the first postpartum year in a large sample of healthy pregnant 
women. The secondary aim was to study possible predictors of CTS symptoms at 12 months 
postpartum. 
METHODS
Participants and procedure 
Criteria for participation and the procedure for this study were described in detail elsewhere.1 
In sum, healthy pregnant women who had their first antenatal visit between January 2013 and 
September 2014 at one of the 17 participating community midwife practices in the southeast 
of the Netherlands were invited to participate in the study. The presence of CTS symptoms was 
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assessed at 32 weeks in 1,527 pregnant 
women and complete data up to 12 months 
postpartum were available for 1,044 of these 
women. Figure 1 presents a flow chart of the 
inclusions for the current study. 
At 32 weeks’ gestation and one week post-
partum (regarding the last weeks of preg-
nancy), women were asked for the three 
key symptoms of CTS during the previous 
period of gestation: “Did you suffer from any 
of the following symptoms during preg-
nancy: pain, tingling sensations or numb-
ness in hands or wrists?”. Moreover, they 
were asked if the symptoms were bilateral 
and at what term of gestation they started. 
Positive cases subsequently completed the 
Boston Carpal Tunnel Questionnaire (BCTQ), 
a disease specific questionnaire to evaluate 
the severity of symptoms and hand function 
impairment. The BCTQ consists of two differ-
ent scales: the Symptom Severity Scale (SSS, 
11 items) and the Functional Status Scale (FSS, 8 items), both scales result in a mean score from 
1 to 5.12,13 In addition to the questionnaires during pregnancy, women filled out questionnaires 
at 6 weeks, 4 months, 8 months and 12 months postpartum. At every time point, they were 
asked: “Do you still suffer any of the following symptoms: pain, tingling sensations or numbness 
in hands or wrists?”. Women also filled out the Edinburgh Depression Scale (EDS) to evaluate 
depressive symptoms. The EDS is the most widely worldwide used self-rating scale to assess 
depressive symptoms during the postpartum period and has also been validated in Dutch post-
partum women.14 The EDS consists of 10 items with total score ranges from 0 to 30, with higher 
scores indicating more symptoms of depression.15 The reliability values of the EDS indicated by 
Cronbach’s alpha-coefficient during the postpartum period varied between 0.82 and 0.84. 
Statistical analyses 
Data were analyzed using SPSS 22.0 (SPSS Inc., Chicago, IL). Descriptive data are presented as 
frequencies and corresponding percentages or means and standard deviations. Differences 
between groups were analyzed using t-tests for continuous variables and χ2-tests for categorical 
variables. A p-value <.05 was considered significant. Effect sizes were evaluated using Cohen’s d 
for t-tests and Cramer’s V for χ2-tests.16 For Cohen’s d, .2, .5 and .8 are considered small, medium 
and large effect sizes, respectively. For Cramer’s V, .1, .3 and .5 are considered small, medium 
Figure 1 Flow chart of inclusions for the current study. 
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and large effect sizes, respectively, for df = 1. Subsequently, within the group of women who re-
ported CTS symptoms during pregnancy, a multiple logistic regression analysis was performed, 
with persistence of CTS at 12 months postpartum as the dependent variable and BCTQ scores 
during pregnancy as independent variable, adjusted for bilateral symptoms, early onset of symp-
toms, parity, age and mean depression scores postpartum. Postpartum depression scores were 
calculated as the grand mean EDS scores of 6 weeks, 4, 8 and 12 months postpartum, to correct 
for incidental high or low scores. 
RESULTS
Baseline BCTQ and general characteristics data were available of 1,527 women and complete 
data up until 12 months postpartum were available of 1,044 women (68%). We compared base-
line characteristics between women with (n = 483) and without (n = 1,044) missing data at 12 
Table 1 Baseline characteristics of the 1,044 women included in the 12 months follow-up study.
Characteristic n (%) Mean SD
Demographic features






Educational level      
high 752 (72.0)
low 292 (28.0)
Marital status      
With partner 1039 (99.5)
Job   994 (95.2)    
Obstetric features
Parity        
Primiparous 521 (49.9)
Previous abortion 252 (24.1)    
Unplanned pregnancy 42 (4.0)    
BMI pre-pregnancy   23.8 3.8






months postpartum. Women with missing data were less highly educated (57% vs. 72%, χ2 (1, N 
= 1,527) = 33.3, p <.001, V = .15), more often multiparous (58% vs. 50%, χ2 (1, N = 1,527) = 9.1, p = 
.003, V = .08), less often had a partner (99% vs. 100%, χ2 (1, N = 1,527) = 4.0, p = .046, V = .08) and 
had a higher mean EDS score during pregnancy (5.2 vs. 4.5, p = .001, d = .19). These differences, 
although significantly different, showed low effect sizes. Age and BMI did not differ between 
women with and without missing data. Within women with CTS symptoms, mean BCTQ scores 
during pregnancy did not differ between women with and without missing data at 12 months 
postpartum. 
In the present study, 354 of 1,044 women (34%) reported one or more of the three key symp-
toms of CTS during pregnancy. Of these 354 cases, 163 (46%) developed symptoms before the 
third trimester and they had a total mean BCTQ score of 1.65 (0.63), mean SSS score of 1.77 (0.67) 
and mean FSS score of 1.48 (0.63). Moreover, 54 (15%) still reported these key symptoms at 
12 months postpartum. BCTQ scores during pregnancy were compared between women who 
reported persisting CTS symptoms at 12 months postpartum (n = 54) and those who did not (n 
= 300). Scores of women with persisting symptoms were significantly higher on the BCTQ (1.65 
(0.63) vs. 1.44 (0.44), p = .026), SSS (1.77 (0.67) vs. 1.55 (0.45), p = .025) and FSS (1.48 (0.63) vs. 1.29 
(0.43), p = .040). The prevalence and persistence of CTS symptoms during the first postpartum 




















Figure 2 Percentage of women who reported CTS during pregnancy up to 12 months postpartum. 
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As can be seen, 35% of women reported CTS symptoms during pregnancy, which dropped to 
11% at 6 weeks postpartum and further to 6% at 4 months postpartum, to remain more or less 
stable until 12 months postpartum: 5% of the total sample (n = 1,044) still reported CTS symp-
toms at 12 months postpartum, which is 15% of women who reported CTS symptoms during 
pregnancy (n = 354). Subsequently, within the group of women who reported CTS symptoms 
during pregnancy, a multiple logistic regression analysis was performed with persistence of CTS 
at 12 months postpartum as dependent variable and mean BCTQ score during pregnancy as in-
dependent variable, adjusted for confounders as bilateral symptoms, onset of symptoms during 
pregnancy, parity, age and mean depression scores on the EDS postpartum. Higher BCTQ scores 
during pregnancy (OR = 1.93, 95% CI [1.08-3.45]), early onset of symptoms during pregnancy 
(OR = 2.88, 95% CI [1.45-5.72]) and higher mean EDS scores postpartum (OR = 1.11, 95% CI 
[1.03-1.19]) were significantly related to persistence of CTS at 12 months postpartum. 
DISCUSSION 
Main findings 
In the present study, the prevalence of self-reported carpal tunnel syndrome symptoms during 
pregnancy was 34%, of whom 15% reported persisting symptoms at 12 months postpartum. 
Higher BCTQ scores during pregnancy, early onset CTS of symptoms during pregnancy and 
depression symptoms postpartum increase the likelihood of persisting CTS symptoms at 12 
months postpartum. 
Strengths and weaknesses
Strengths of this study are the prospective design, the repeated measurements, the adjustment 
for comorbid depressive symptoms and the large sample size: 1,044 healthy pregnant women 
were included in the study, of whom 354 reported CTS symptoms during pregnancy, providing 
Table 2 Multiple logistic regression analysis results with the persistence of CTS as dependent variable within the 




bCTQ score during pregnancy 1.93 1.08 3.45 .028*
bilateral CTS symptoms 0.90 0.44 1.83 .762
Early onset of CTS symptomsa 2.88 1.45 5.72 .003*
Multiparity 1.45 0.76 2.77 .258
age 0.96 0.88 1.05 .341
Mean EDS score postpartum 1.11 1.03 1.19 .009*
a Before third trimester of pregnancy * p-value <.05.
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considerable power and an accurate representation of the general population. The study also 
has several limitations. First, CTS was not diagnosed either clinically or using electrodiagnostic 
testing. However, the most important diagnostic criteria in clinical practice are patient reported 
symptoms. Tests such as the Tinel sign or Phalen’s test have poor sensitivity and specificity.17,18 
Moreover, the majority of patients with clinical CTS but a negative electrodiagnostic test benefit 
from treatment, including surgery.19 Secondly, it is unclear whether the CTS symptoms were 
already present before pregnancy. The prevalence of CTS in women between 18 and 40 years 
is unknown. However, women in general are at risk for CTS and in the general population CTS 
is reported to develop especially between 40 and 60 years,20 reducing the likelihood in the cur-
rent study that CTS symptoms were present before pregnancy. Thirdly, one third of the women 
dropped out at 12 months postpartum and some baseline characteristics of these women were 
significantly different from the completers. However, the absolute differences and effect sizes 
were small, decreasing the likelihood of bias. Moreover, 68% completion in a large sample during 
12 months follow-up can be regarded as acceptable. We also compared the characteristics of 
the current study sample (n = 1,044) with those of our previous study (n = 639).1 There were no 
significant differences between the two samples based on all baseline characteristics (data not 
shown).  
Interpretation 
The sample of women in the current study was similar to other studies based on age and BMI.3,4,21 
The sample from Turgut et al.5 was slightly younger, while Padua et al.21 reported more primipa-
rous women. In line with the study by Padua et al.4, earlier onset of symptoms was a predictive 
factor for persistent CTS symptoms at follow-up. However, their reported prevalence of persisting 
CTS symptoms at 12 months postpartum was much higher (54% vs. 15% in the current study), 
but their sample size was much smaller (n = 37) compared to the current study and they did 
not report the time of onset of symptoms in their sample. Moreover, at one year follow-up, they 
re-evaluated 37 women (78%) of the 47 who had CTS symptoms during pregnancy. They did not 
report how women were selected for re-evaluation and only compared characteristics to the 
original sample based on age and CTS data, so selection bias was not eliminated. Compared to 
the current study, Turgut et al.5 reported a very small prevalence of pregnancy-related CTS at one 
year postpartum (4%). Their sample size of women with pregnancy-related CTS was also much 
smaller (n = 46). Moreover, many women in their sample developed CTS in the third trimester 
(85%, compared to 54% in the current study) and we showed that women who develop CTS in 
the third trimester are more likely be asymptomatic at 12 months postpartum. Moreover, the ini-
tial evaluation for CTS during pregnancy was based on patient-reported symptoms at the time 
of delivery. However, they did not specify when these women were asked about CTS symptoms 
and baseline characteristics of the participants (such as education) were not reported. 
Higher postpartum depression scores on the EDS were also a predictor for CTS symptoms at 
12 months postpartum. It is well known that patients with depression in general report higher 
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levels of somatic symptoms. Especially patients who report chronic pain also experience prob-
lems in a range of psychological domains, such as depression, anxiety and general emotional 
functioning.9 Therefore, in women with long lasting CTS symptoms, the existence of depression 
should be considered. These women should be offered a depression screening tool and – if 
positive – offered an intervention, given the known negative impact of maternal depression on 
child development.22 
Conclusion
Pregnancy-related CTS symptoms do not resolve in all women who report symptoms during 
pregnancy: one out of six women with CTS symptoms during pregnancy still report symptoms 
at 12 months postpartum, especially women with early onset of symptoms and more severe 
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Effectiveness of mechanical traction as a non-
surgical treatment for carpal tunnel syndrome 
compared to care as usual: study protocol for a 
randomized controlled trial 





background: Carpal tunnel syndrome (CTS) is a common condition (prevalence of 4%) where 
the median nerve is compressed within the carpal tunnel resulting in numbness, tingling and 
pain in the hand. Current non-surgical treatment options (oral medication, corticosteroid in-
jections, splinting, exercise and mobilization) show limited effects, especially in the long-term. 
carpal tunnel release (CTR) surgery is effective in 70 to 75% of patients, but is relatively invasive 
and can be accompanied by complications. In an observational study, mechanical traction 
proved to be effective in up to 70% of patients directly after treatment and in 60% after two years 
follow-up. This randomized controlled trial (RCT) will examine the effectiveness of mechanical 
traction compared to care as usual in CTS. 
Methods/Design: Patients diagnosed with CTS will be recruited from an outpatient neurology 
clinic and randomly assigned to the intervention group (mechanical traction) or the control 
group (care as usual). Participants in the intervention group will receive 12 treatments with 
mechanical traction during six consecutive weeks. Primary outcome is symptom severity and 
functional status, which are measured with the Boston Carpel Tunnel Questionnaire (BCTQ). 
Secondary outcomes are quality of life (WHOQOL-BREF), health related resource utilization and 
absenteeism from work. Outcomes will be assessed at baseline, and at 3, 6 and 12 months after 
inclusion.
Linear mixed effect models will be used to determine the change from baseline at 12 months 
on the BCTQ, WHOQOL-BREF, absenteeism from work and health related resource utilization. 
The baseline measurement, change from baseline at three and six months, as well as duration 
of symptoms until inclusion, age, gender and co-morbidity will be included as covariates. The 
Pearson’s correlation coefficient will be generated to assess the correlation between depression 
and anxiety and treatment outcome. 
Discussion: Since current non-surgical treatment options are not effective long-term and CTR is 
relatively invasive, there is a need for an effective and non-invasive treatment option. Mechanical 
traction is a safe treatment option that may provide a good alternative for the usual care. Con-
sidering the prevalence of CTS, the study is of great clinical value to a large patient population. 
Trial registration: Clinical Trials NL44692.008.13 (registered on September 19, 2013).
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baCKGROUND
Carpal tunnel syndrome (CTS) is a common compressive neuropathy in which the median nerve 
is compressed at the level of the carpal tunnel.1,2 CTS can occur in one or both hands and is 
either idiopathic (spontaneous) or dynamic (only during certain movements). The compression 
leads to numbness and tingling in the first three fingers and the radial side of the ring finger, par-
esthesia, pain and (in severe cases) weakness. The symptoms are often worse at night or after use 
of the hand.2 Prevalence is estimated to be about 4% in the general population3 and up to 10% in 
the working population.4 Although CTS can occur at any age, it most commonly occurs between 
40-60 years and its prevalence is higher in women compared to men.1 Obesity, diabetes mellitus 
and alcohol abuse are risk factors for developing CTS.1 Occupation has been identified as an 
environmental risk factor: vibration, hand force and repetition are associated with increased risk 
for developing CTS.5 Furthermore, there is a psychological component to the experience of CTS 
symptoms: depression has been reported as a predictor of pain in CTS patients.6
CTS can be diagnosed using electromyography (EMG). Compression of the median nerve can 
lead to damage and dysfunction of the myelin sheath, resulting in slowed conduction velocity, 
which can be detected using EMG.7 Treatment options to reduce the compression and relieve 
symptoms can be roughly divided into surgical and non-surgical procedures. Non-surgical, 
less invasive treatment options are numerous, including oral medication, corticosteroid injec-
tions, splinting, exercise and mobilization interventions.8-12 However, there is only short-term 
or limited evidence of benefit for these interventions. Many (nonsteroidal) drugs did not prove 
to be significantly superior compared to placebo.12 There is only limited evidence for the effec-
tiveness of splinting, exercise and mobilization interventions.10,11 Local corticosteroid injections 
provide considerable symptom relief and therefore show the best results of the nonsurgical 
treatments.8,9 However, corticosteroids seem to merely suppress CTS symptoms and the positive 
effects do not last.8,13 The treatment effect diminishes over time and half of patients who receive 
corticosteroid injections experience recurrence of symptoms within a year.13
Compared to non-surgical treatment, surgery is the only known treatment option that shows 
long-term positive effects.14 The principle of the procedure, called carpal tunnel release (CTR), 
is to decompress the nerve by dividing the transverse carpal ligament.15 Evidence suggests 
that CTR is a more effective treatment for CTS than splinting or oral medication, especially 
long-term.15 However, up to 30% of patients who underwent CTR experience persistence or 
recurrence of CTS symptoms in the long-term or suffer from complications.16,17 Therefore, there 
is still a clear need for an alternative non-invasive therapy, possibly making surgery redundant 
for a sub-category of patients. 
Another promising non-surgical treatment for CTS is mechanical wrist traction using the Phys-
trac traction device. The Phystrac applies repeated traction movements to the wrist in different 
positions using gravitational force. Brunarski et al.18 described four case studies using mechanical 
traction that showed promising results. In an observational study, physical therapists reported a 
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success rate of 70% with mechanical traction immediately post-treatment,19 and 60% after two 
years follow-up.20 However, until now, no randomized controlled trial (RCT) has been performed 
to show clinical evidence for the effectiveness of mechanical traction as compared to care as 
usual (surgical and non-surgical intervention). 
Hypothesis and objectives
The purpose of this study is to evaluate the effectiveness of mechanical traction in alleviating 
symptoms and improving hand function in patients with CTS compared to care as usual. The 
primary outcome is the change from baseline in symptom severity and functional status at 12 
months, which is measured using the Boston Carpal Tunnel Questionnaire (BCTQ). Change from 
baseline in functional status and symptom severity at three and six months will be used as covari-
ates. As secondary outcomes, we will assess quality of life, health related resource utilization and 
absenteeism from work. Tertiary outcome is the impact of psychological distress on treatment 
outcome. 
We hypothesize that hand function and symptom severity will significantly improve more in CTS 
patients receiving 12 treatments with mechanical traction compared to CTS patients who receive 
care as usual after 12 months. Moreover, 12 treatments with mechanical traction will result in less 
absenteeism from work, a higher quality of life, and less health related resource utilization com-
pared to care as usual in CTS patients after 12 months follow-up. Furthermore, a higher degree of 
depression and anxiety at baseline will result in a lower treatment effect in CTS patients. 
METHODS / DESIGN
Study design
This study is designed as an RCT. Eligible patients diagnosed with CTS will be recruited from 
the outpatient neurology clinic of VieCuri Medical Center in Venlo, the Netherlands. They will be 
randomly allocated to the intervention (mechanical traction) or control (care as usual) group. 
The intervention group will receive 12 treatments with mechanical traction using the Phystrac 
traction device. The control group will receive care as usual, which may involve an expectant 
strategy, splinting, drug therapy, local corticosteroid injections or CTR. 
Eligibility
Adult men and women (aged 18 to 80 years) who have been diagnosed with CTS by means of 
a positive EMG will be invited to participate in our study. They have to be physically able to visit 
the outpatient clinic twice a week and sit in an upright position for at least 20 minutes. Patients 
with a previous history of CTS surgery will be excluded as well as those with insufficient under-
standing of the Dutch language. In addition, patients who have been diagnosed with another 
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known (rare) cause of neuropathy, or who are suffering from a severe psychiatric disorder, such 
as personality disorder, schizophrenia or bipolar disorder will also be excluded. 
Recruitment, screening process and enrolment 
Neurologists will select eligible patients based on the in- and exclusion criteria. During the visit 
to the outpatient clinic, the neurologist will inform patients about the study. In addition, the 
patients will receive an information letter. Two weeks after their visit to the outpatient clinic 
they will be phoned by the researcher and asked whether they are interested to participate 
in the study. Eligible patients who are willing to participate will be invited for an intake visit at 
the hospital. During this intake, the eligibility of the patients will be double-checked and there 
will be an opportunity for the patients to ask additional questions about the study. Full written 
informed consent will be obtained from each participating patient. Subsequently, the patients 
will receive an interview and complete a set of questionnaires, which will result in the baseline 
measurement. 
Ethical approval
The study protocol was approved by the Medical Ethical Committee of the St. Elisabeth Hospital 
in Tilburg, the Netherlands in August 2013 (reference number P1340). The RCT has been regis-
tered under the trial number: NL44692.008.13.
Randomization
After inclusion, every patient will be randomly assigned to either the intervention or the care 
as usual group. Before the start of the study, a list of 200 random numbers of 1 (intervention) 
or 2 (care as usual) will be created using SPSS, version 21 (SPSS Inc., Chicago, IL, USA). The ran-
dom numbers will be uniformly distributed. The list will be kept at the secretary’s office of the 
outpatient neurology clinic. At the end of the intake, a participant number will be assigned 
to the patient. The secretary will refer to the generated random list and inform the researcher 
to which group the patient is allocated. The random list cannot be edited and is concealed 
from the researcher. The above described process of randomization will ensure objectivity of the 
researcher and will eliminate bias in the participants’ group allocation. 
blinding
Blinding of patients or practitioners is not possible due to the current study design. As described 
previously, group allocation will not be known to both the patient and researcher during the 
intake. This allows for an objective baseline measurement.
Intervention: Phystrac mechanical traction therapy
Patients in the intervention group will receive 12 treatments (twice a week for a period of six 
weeks) with the Phystrac mechanical traction device (type GR 10). The Phystrac provides me-
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chanical traction to the wrist using weights between 1 and 18 kg. One treatment takes 10 to 15 
minutes per diseased hand. The patient will be seated beside the traction device on a seat that 
is adjustable in height. The patient will put his arm on the arm support of the device and will 
be secured with two Velcro straps; one above and one below the elbow. Another Velcro strap 
which is attached to the weights will be fastened around the wrist with the palm of the hand 
upwards. The weight is set at 5 kg for women and 7 kg for men during the first treatment session. 
Every following treatment session, the weight is increased with 1 kg for women and 2 kg for 
men until 10 kg for women or 13 kg for men, or until the mechanical traction becomes painful 
or uncomfortable for the patient. When the patient is fitted correctly, the weight will be lowered 
and provides a pulling force on the wrist. After eight seconds the weight is lifted, providing a rest 
period of four seconds. This cycle will be repeated ten times. After 10 traction movements, the 
device stops and the researcher will rotate the wrist straps 30 degrees supination, after which 
another 10 traction movements will be provided. After that, a third set of 10 traction movements 
will be provided in 30 degrees pronation position. In total, 30 traction movements will be ap-
plied during each treatment. During the six weeks of treatment, patients will not receive other 
forms of treatment. After the six weeks of treatment, patients are allowed to receive usual CTS 
care when mechanical traction was not sufficient. 
Control group: ‘care as usual’
The control group will receive ‘care as usual’, which means they will receive regular treatment 
from their usual health care provider. Patients may adopt an expectant approach or receive 
treatment in the form of a wrist splint, local corticosteroid injections or CTR. Forms of treatment 
received in both groups will be documented during the full length of the study using question-
naires and medical records.  
Outcome measurements
Measurement time points and questionnaires used are shown in Table 1. Data collection will 
take place at baseline (before the start of the intervention) and at 3, 6 and 12 months after 
baseline in both groups. Additional data of the intervention group will be collected at two other 
time points: at 3 weeks (after 6 treatments) and at 6 weeks (after 12 treatments = immediately 
post treatment). Information about patient attendance and drop-out will be recorded continu-
ously. Patients of both groups will receive the follow-up questionnaires at 3, 6 and 12 months 
via internet or a paper-and-pencil version with an addressed return envelope, depending on the 
participant’s preference. 
Primary outcome measure
Functional status and symptom severity 
Self-reported functional status and symptom severity will be measured using the Boston Carpal 
Tunnel Questionnaire (BCTQ).21,22 The BCTQ is a disease-specific questionnaire referring to a 
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typical 24 hour period in the past two weeks. It consists of two different scales: the Symptom 
Severity Scale (SSS) and the Functional Status Scale (FSS). The SSS comprises 11 questions about 
symptom severity, while the FSS consists of 8 daily activities which are rated based on degree 
of difficulty. The SSS and the FSS will be rated on a five-point scale. Both scales result in mean 
scores between 1 and 5, where greater impairment is represented by higher scores. The BCTQ 
is responsive to clinically relevant change and therefore an appropriate measure for treatment 
outcome.21 It has been validated and is used in multiple studies to assess improvement in CTS 
symptoms over time 14, also in the Netherlands.13,23 
Secondary outcome measures
Quality of life
As a secondary outcome measure, self-reported quality of life will be measured using the abbre-
viated Dutch version of the World Health Organization Quality of Life (WHOQOL-BREF).24,25 The 
WHOQOL-BREF measures quality of life in four domains: physical health, psychological health, 
social relationships and environment. In addition, it includes one facet on overall quality of life 
and general health. The WHOQOL-BREF consists of 26 items referring to the past two weeks, and 
which can be scored on a five-point scale, where a higher score represents a better quality of life. 
The WHOQOL-BREF has been proven to be a valid and reliable instrument.24,25
Absenteeism from work
The number of days off work of each patient will be collected using a non-standardized ques-
tionnaire. Furthermore, participants will be asked whether they are on sick leave or have been 
because of their CTS complaints.
Table 1 Measurements and time points. 
Measure Questionnaire
Measurement time points
T0 V1 V2 T1 T2 T3
Patients’ background (demographics, clinical)  - X     X X X
CTS symptom severity and functional status BCTQ X X X X X X
Quality of life WHOQOL-BREF X   X X X X
Depression and anxiety PHQ-4 X X X X X X
Health related resource utilization Non-standardized X         X
Absenteeism from work Non-standardized X     X X X
T0 = baseline, V1 = 3 weeks (only intervention group), V2 = 6 weeks (only invention group), T1 = 3 months, T2 = 6 
months, T3 = 12 months, BCTQ = Boston Carpal Tunnel Questionnaire, WHOQOL-BREF = World Health Organization 
Quality of Life questionnaire abbreviated version, PHQ-4 = Patient Health Questionnaire-4
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Health care related resource utilization 
Patients will be asked how many times they visited a professional caregiver (general practitioner, 
physiotherapist, psychologist, specialist or other health care providers) in the past 12 months, if 
they spent time in the hospital or used medication via a non-standardized questionnaire. 
Tertiary outcome measures
Depression and anxiety 
The four-item Patient Health Questionnaire (PHQ-4) will be used to measure self-reported 
depression and anxiety. The questionnaire consists of two items on depression and two on 
anxiety, referring to the past two weeks. A higher score represents a higher level of anxiety and 
depression. The PHQ-4 is a reliable instrument that has been validated in a general population.26 
Demographic and clinical variables
Demographic variables will be collected during the intake interview. Information about age, 
education, job status, nationality, residence and marital status will be documented. Also, BMI 
and life style habits (smoking, alcohol intake, physical activity) will be documented at baseline. 
Finally, clinical variables including medication and the existence of co-morbidity (for example, 
diabetes, cardiovascular disease, COPD) will be verified from the patient’s medical record forms 
after obtaining written informed consent. 
Statistical analysis 
Sample size and power calculation
The sample size calculation is based on a clinically relevant improvement from baseline on 
the functional and symptom severity scores of the BCTQ after 12 months follow-up. Sixty-four 
patients need to be included per treatment arm to statistically detect a minimum effect size of 
d = 0.5 between mean BCTQ scores of both groups with a power of 0.8 and a two-sided alpha 
of 0.05. A total of 200 patients will be included (100 patients per treatment arm), taking into 
account possible drop-out. 
The following outcomes are defined. A completer is a patient who participated in at least 70% of 
the intervention sessions and the assessments. A responder is a patient who will have a reduc-
tion of 0.74 of the mean score (minimal clinical important difference) on the BCTQ compared to 
baseline.21 A drop-out is a patient with less than 70% of the intervention or the follow-up data. 
Planned analyses  
The baseline characteristics of those who complete and will drop out during follow-up will be 
compared by means of an independent t-test for continuous data and by χ2-tests for categorical 
data. All analyses will be based on the intention-to-treat principle. Linear mixed effect models 
will be used to compare the change from baseline at 12 months between groups on the BCTQ, 
WHOQOL-BREF, absenteeism from work and health related resource utilization. Linear mixed 
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effect models are able to adjust for missing values and are therefore used to avoid loss of in-
formation.27 The baseline, three months and six months measurements, as well as duration of 
symptoms until inclusion, age, gender and co-morbidity will be included as covariates. Taking 
these covariates into account will adjust for differences within the groups and decrease variance. 
It will also adjust for possible baseline differences between groups.28 When the data are normally 
distributed, Pearson’s correlation coefficients will be generated to examine the relationship be-
tween treatment outcome and depression and anxiety.
DISCUSSION
This paper describes the design for an RCT with the purpose to study the effectiveness of 
mechanical traction as a treatment for CTS compared to care as usual. Recruitment started in 
October 2013 in the VieCuri Medical Center in Venlo, the Netherlands. The outpatient neurology 
clinic registers over 400 CTS patients annually of whom about 350 will be eligible. During a pe-
riod of 12 months, these patients will be invited to participate in the RCT. For several reasons, it is 
realistic to predict a response rate of 60%. First, the new treatment is painless and non-invasive. 
Second, in case of a non-responder, the patient can always make a choice for surgery without 
any evidence for poorer prognosis. The predicted sample size of 200 patients will easily enable 
the researchers in one year to include sufficient patients into the trial with sufficient power.
The clinical relevance of this RCT is substantial. First, CTS is very common, not only in the general 
population (up to 4%), but especially in the working population (up to 10%). Secondly, because 
the prevalence in the working population is relatively high, CTS-related days of sick leave and 
workers’ compensation lead to an economic burden. Absenteeism from work after carpal tunnel 
release (CTR) is on average two to seven weeks.29,30 In the US, cumulative excess loss of earnings 
of 4,443 workers who filed a CTS related workers’ compensation claim was estimated at $197 to 
$382 million over 6 years.31 Thirdly, the long-term benefits of current treatment strategies of CTS 
are far from optimal. Fourth, it is well known that recovery from pain symptoms can be mediated 
by the patient’s mental state, especially anxiety and depression. Pain is a process from nocicep-
tive registration to a subjective experience, which can be influenced by psychological wellbe-
ing.32 Depression has been reported as a predictor of pain intensity in CTS patients.6 Research 
into the mediator effect of emotional distress on the outcome of CTS treatment is limited. Hobby 
et al.33 reported a significant association between BCTQ scores and scores on the depression 
and anxiety scales. Moreover, Lozano Calderon et al.34 reported that patient dissatisfaction and 
perceived impairment after CTR can partly be predicted by depression. 
Up until now, non-invasive CTS treatment mostly consists of splint therapy and corticosteroid 
injections. These treatments have not been proven to be effective in the long-term.8-10 Invasive 
CTR, on the other hand, results in a positive outcome in only 70 to 75% of the patients in the 
long-term.16,17 Mechanical traction using the Phystrac traction device is a promising treatment 
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option. It is non-invasive and has been reported to result in substantial symptom relief in 70% 
of the patients, and in 60% of the patients two years post-treatment.20 However, there is no 
conclusive scientific evidence for the effectiveness of mechanical traction. Therefore, there is 
a clear need for an RCT to compare mechanical traction to regular treatment options, such as 
splint therapy, steroid injections and CTR. 
Improvements in functional status and symptom severity will be measured using the BCTQ. This 
questionnaire has been proven to be a valid and reliable outcome measure.21,22 It is widely used 
in clinical practice to evaluate the recovery of CTS symptoms after treatment. This means that we 
have an easy, user-friendly and quick measure to assess clinical outcome. 
One strength of this study is the additional outcome measures. Apart from clinical measures, 
quality of life, absenteeism from work and health related resource utilization will be measured. 
Another strength of this study is the follow-up length. Many studies only include a few weeks 
or months follow-up, while the current study aims at a 12 months follow-up period. A possible 
limitation of this study is the heterogeneity of the care as usual group. The patients in this group 
can receive different forms of treatment or no treatment at all. However, since this represents the 
general practice in an outpatient neurology clinic, the results of this RCT will provide clinically 
relevant information. 
Since the current treatment options are not effective in all patients, or only short-term, research 
into an alternative, long-term effective treatment option will be of great clinical value. The 
proposed RCT will provide possible evidence for mechanical traction as a new non-invasive 
treatment for CTS. Since 4% of the general population develops CTS, the results of this trial will 
be of benefit to a large patient population. Surgery is often considered a last resort and many 
patients postpone it for as long as possible, resulting in irreversible nerve damage in some cases. 
Furthermore, contrary to CTR, mechanical traction does not interfere with work or other daily 
activities. A less invasive treatment may also have a positive influence on quality of life. Therefore, 
mechanical traction provides a safe treatment option as an alternative to usual care. 
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background: Carpal tunnel syndrome (CTS) is a common compressive nerve entrapment 
disorder with symptoms of numbness, paresthesia and pain. Carpal tunnel release surgery is 
the only known long-term effective treatment. However, surgery is invasive and up to 30% of 
patients report recurrence or persistence of symptoms or suffer from post-surgical complica-
tions. A promising non-surgical treatment for CTS is mechanical wrist traction. The purpose of 
this study was to evaluate clinical outcomes following mechanical traction in patients with CTS 
compared to care as usual.
Methods: Adult patients (N = 181, mean age 58.1 (13.0) years, 67% women) with electrodiagnos-
tically confirmed CTS were recruited from an outpatient neurology clinic between October 2013 
and April 2015. After baseline assessments, patients were randomized to either the intervention 
group (12 treatments with mechanical traction) or care as usual. The main clinical outcome 
measure was surgery during six months follow-up. In addition, symptom severity was measured 
using the Boston Carpal Tunnel Questionnaire (BCTQ) at baseline, three, and six months follow-
up. 
Findings: The intervention group had fewer surgeries (28%) compared to the care as usual 
group (43%) during follow-up (χ2 (1, N = 181) = 4.40, p = .036). Analyses of the survival curves 
revealed a statistical significant difference between the groups over time (log rank χ2 (1, N = 181) 
= 6.94, p = .008). At six months follow-up, symptom severity and functional status scores had 
significantly decreased from baseline in both groups (p <.001) and the improvements did not 
differ between the two groups.
Interpretation: Mechanical traction is associated with fewer surgical interventions compared to 
care as usual in CTS patients. Reductions in patient-reported symptoms at six months follow-up 
was similar in both groups. The long-term effects of mechanical traction require further evalu-
ation. 
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baCKGROUND
In recent years, concerns have been raised about the large number of invasive treatments per-
formed every year.1 In some cases, initial conservative treatment may be more cost-effective and 
preferred by the patient.2 The benefit of these invasive treatments should be critically evaluated 
compared to more conservative approaches. This especially applies to carpal tunnel syndrome.
Carpal tunnel syndrome (CTS) is a compressive nerve disorder in which the median nerve is 
compressed in the carpal tunnel.3,4 It is very common; the prevalence of CTS in the general 
population in the United States is 5%,5 and in Netherlands about 0.6% in men and between 
5.8 and 9.2% in women.6-8 CTS can occur in only one or both hands. The compression leads to 
numbness, paresthesia and pain, especially in the first three fingers and the radial side of the 
ring finger, which are innervated by the median nerve. Symptoms are typically worse at night.3 
In severe cases, the compression can cause permanent nerve damage leading to thenar atrophy 
and sensory disturbances in the part of the hand which is innervated by the median nerve.3 
Although CTS can occur at any age, the condition is most commonly observed between the 
ages of 40 – 60 years and the prevalence is higher in women compared to men.4 
CTS can be diagnosed using electrodiagnostic testing to detect slowing of conduction velocity 
that results from median nerve compression-related damage and dysfunction of the myelin 
sheath.9 Treatment options to relieve symptoms are either surgical or non-surgical. Non-surgical, 
less invasive treatment options include oral non-steroidal drugs, corticosteroids (injections), 
splinting, exercise and mobilization interventions.10-14 There is only short-term or limited evi-
dence of benefit for these interventions. Many (nonsteroidal) drugs are not significantly superior 
to placebo.12 Local corticosteroid injections provide considerable symptom relief,10,11 but seem 
to primarily suppress CTS symptoms and the treatment effect diminishes over time.10,15 There 
is only limited evidence for the effectiveness of splinting, exercise and mobilization interven-
tions.13,14
Surgery is the only known treatment option with long-term positive effects.16 The principle of 
the procedure, called carpal tunnel release, is to decompress the nerve by dividing the trans-
verse carpal ligament.6 Evidence suggests that surgery is a more effective treatment for CTS than 
conservative treatment (splinting or steroid injections).16-18 However, surgery is associated with 
several disadvantages: some patients suffer from sustained surgery-related pain, hand weakness 
or complications from surgery.19 Patient satisfaction rates of carpal tunnel release surgery vary 
between 70 to 80%.7,20-23 The remaining 20-30% report persistence or recurrence of CTS symp-
toms or suffer from complications.21,22 The reported frequency of re-operation rate is between 
3 and 12%.21 Therefore, there is a clear need for an alternative, preferably non-invasive, therapy 
for CTS.
A promising non-surgical treatment for CTS is mechanical wrist traction. This intervention in-
volves repeated traction movements to the wrist in different positions using gravitational force. 
Brunarski et al.24 described four case studies using mechanical traction that showed promising 
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results. In an observational study among 78 CTS patients, treatment with mechanical trac-
tion resulted in a success rate of 70% immediately post-treatment,25 and 60% after two years 
follow-up.26 However, no randomized controlled trial (RCT) has been performed to show clinical 
evidence for the effectiveness of mechanical traction as compared to care as usual (surgical and 
non-surgical interventions). 
The purpose of this study was to evaluate the impact of mechanical traction in patients with 
CTS compared to care as usual using a randomized controlled trial. The main clinical outcome of 
the study was surgery for carpal tunnel release during six months follow-up. We also examined 
differences between mechanical traction versus usual care on the decrease in symptom severity 
and hand function problems at follow-up. 
METHODS 
Participants
Patients diagnosed with CTS were recruited from the outpatient neurology clinic of VieCuri 
Medical Center in Venlo and Venray, the Netherlands between October 2013 and April 2015. 
Adult men and women (aged 18 - 80 years) who were diagnosed with CTS by means of elec-
trodiagnostic testing were invited to participate in the study. Electrodiagnostic values were 
considered abnormal if there was a difference greater than 0.5 ms on distal sensory latency 
(DSL) between ulnar and median nerve in Digit IV or between radial and median nerve in Digit 
I, a distal motor latency (DML) greater than 3.7 ms across the wrist to digit I of the median nerve 
(measured in the Abductor Pollicis Brevis), or a difference greater than 0.4 ms in the median 
nerve across the wrist compared to palm to digit III. The criteria used for diagnosis were at least 
two abnormal measures.9 
Patients with a previous history of CTS surgery were excluded as well as those with insufficient 
understanding of the Dutch language. In addition, patients who were diagnosed with another 
known (rare) cause of neuropathy or who suffered from a severe psychiatric disorder, such as 
personality disorder, schizophrenia or bipolar disorder were also excluded. During the visit to 
the outpatient clinic, the neurologist provided eligible patients with oral and written informa-
tion about the study. Between October 2013 and April 2015, 500 eligible patients were invited 
of whom 181 patients agreed to participate and were randomized to the mechanical traction 
intervention or care as usual. Main objections to participation were lack of time and transport 
problems, preventing patients to visit the outpatient clinic twice a week. Patients who were 
willing to participate were invited for an interview at the hospital, at the start of which the eligi-
bility of the patients was double-checked and full written informed consent was obtained. This 
included permission to check medical data in the patients record forms. Figure 1 presents a flow 
chart of participant inclusions, treatment condition and data availability. 
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The study protocol was approved by the Medical Ethical Committee of the St. Elisabeth Hospital 
in Tilburg, the Netherlands in August 2013 (protocol #P1340). The trial was registered at Clinical 
Trials on September 19, 2013 (trial registration #NL44692.008.13).
Procedure
After inclusion, patients were interviewed by the research staff (MM), during which they also 
answered a set of paper-and-pencil questionnaires. Demographic variables (age, education, job 
status, nationality and marital status) were documented. Also, BMI and life style habits (smok-
ing, alcohol intake) were assessed. Results of the electrodiagnostic test were obtained from the 
patient medical record forms. 
After the baseline interview, the 181 patients were randomized into two groups: the traction 
intervention (n = 94) or care as usual (n = 87). As shown in Table 1, the groups were comparable 
on demographic and clinical variables and the slight imbalance in the group sizes resulted from 
the randomization procedure, which was based on a priori group allocation of the first 200 
participants.27 The patients filled out the Boston Carpal Tunnel Questionnaire (BCTQ) at baseline 
Figure 1 Flow chart of inclusions.
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and at three and six months after inclusion, either through an email invitation online or a paper-
and-pencil version which they received at their home address. There were significantly more 
drop-outs in the care as usual group (36%, n = 31) compared to the intervention group (13%, n 
= 12: χ21 = 13.0, p <.001). 
Intervention: Phystrac mechanical traction therapy
Patients in the intervention group received 12 treatment sessions (twice a week for a period 
of six weeks) with the Phystrac mechanical traction device (type GR 10). The Phystrac provides 
mechanical traction to the wrist using weights between 1 and 18 kg. One session takes 10 to 
15 minutes per affected hand. The weight was set at 5 kg for women and 7 kg for men during 
the first session. Every following session, the weight was increased with 1 kg for women and 2 
kg for men until 10 kg for women or 13 kg for men, or until the mechanical traction became 
uncomfortable for the patient. Twelve treatments is considered sufficient for most patients.
Control group: ‘care as usual’
The control group received ‘care as usual’, which meant they received regular treatment from 
their usual health care provider. Patients adopted an expectant approach or received treatment 
in the form of a wrist splint, local corticosteroid injections or carpal tunnel release surgery. Forms 
of treatment received in both groups were documented during the full length of the study using 
questionnaires and checking the medical records.  
Outcome measures 
The main outcome variable was whether patients received surgery during follow-up, which was 
derived from the patient medical records. Self-reported functional status and symptom severity 
were measured using the Boston Carpal Tunnel Questionnaire (BCTQ), which was developed at 
Harvard.28,29 The BCTQ is a disease-specific questionnaire referring to a typical 24 hour period 
in the past two weeks. It consists of two different scales: the Symptom Severity Scale (SSS) and 
the Functional Status Scale (FSS). The SSS comprises of 11 questions about symptom severity, 
while the FSS consists of 8 daily activities which are rated based on degree of difficulty. The SSS 
and the FSS were rated on a five-point scale. Both scales result in mean scores between 1 and 5, 
where greater impairment is represented by higher scores. The total BCTQ score was calculated 
as the mean of all the items. The BCTQ is responsive to clinically relevant change and therefore 
an appropriate measure for treatment outcome.28 It has been validated and is used in multiple 
studies to assess improvement in CTS symptoms over time,16 also in the Netherlands.7,15 
Statistical analyses 
Data are presented as mean (SD) or percentages. Independent samples t-test and χ2-tests were 
used to compare baseline characteristics between groups, as well as between total eligible and 
included patients and between patients with missing data versus patients with complete data 
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at six months follow-up. Time-to-first-event (surgery) curves were displayed for the intervention 
and care as usual groups using Kaplan-Meier analysis. Cox proportional hazards analysis was used 
with group, age, sex, pre-enrolment symptom duration, dominant hand involved and baseline 
BCTQ score as predictor variables. The proportional hazards assumption was visually checked 
based on the survival curves and the log minus log survival versus log of survival time curves for 
the different covariates. Analyses were performed using an intention-to-treat approach: the pa-
tients remained in the group to which they were allocated at baseline, regardless of the interim 
treatments or drop-out during follow-up. To avoid loss of data, missing data were imputed using 
multiple imputation. Statistical analyses were performed using the Statistical Package of Social 
Science (SPSS, 22.0).
RESULTS
Baseline characteristics of the sample are presented in Table 1. The mean age was 58.1 (13.0) 
years, 67% was female and 25% had had CTS complaints for longer than three years. The care 
as usual and intervention groups did not differ based on any of the baseline characteristics. We 
also compared the patients included in the trial (N = 181) to all eligible patients on age, sex 
and affected hand. Patients who participated in the trial were older than the overall group of 
eligible patients (58.1 (13.0) and 54.8 (14.4), respectively; p = .011). Moreover, within the included 
patients, we compared baseline characteristics of the completers with those of the drop-outs 
at six months follow-up. The patients who dropped out were significantly younger than the 
completers in the whole study population (53.7 (14.9) and 59.5 (12.1), respectively; p = .010), as 
well as within the intervention (p = .036), but not the care as usual group (p = .157). 
Effects of mechanical traction on surgery during six months follow-up
At six months follow-up, 26 (28%) patients in the intervention group had surgery, compared 
to 37 (43%) in the care as usual group (χ2 (1, N = 181) = 4.40, p = .036). Kaplan-Meier survival 
curves showed significant group differences over time (Figure 2; log-rank χ2 (1, N = 181) = 6.94, 
p = .008). Time to surgery was shorter (median = 41 days) in the care as usual group than in the 
intervention group (median = 90 days). The proportional hazards assumption was verified. Cox 
proportional hazards analysis revealed a significantly higher rate of surgery during six months 
follow-up in those receiving care as usual (HR = 2.27, 95% CI [1.35-3.80]), as well as in those with 
a symptom duration of more than three years (HR = 1.89, 95% CI [1.11-3.24]), adjusted for age, 
sex, dominant hand involved and BCTQ score at baseline.
Symptom status at follow-up
At six months follow-up, symptom severity and functional status scores did not differ between 
the intervention and care as usual group (Table 2). When comparing the change in scores from 
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baseline to six months follow-up (paired samples t-test) based on intention-to-treat, the BCTQ 
scores decreased significantly both in the intervention (p <.001) as well as the care as usual 
group (p <.001). 
Table 1 Baseline characteristics of the sample (N = 181).
Total (N = 181) Intervention (n = 94) Care as usual (n = 87) p
Mean (SD) n (%) Mean (SD) n (%) Mean (SD) n (%) t χ2
 Demographic features
age (in years) 58.1 (13.0) 59.0 (12.4) 57.2 (13.7) .339
Sex .454
male 59 (32.6) 33 (35.1) 26 (29.9)
female 122 (67.4) 61 (64.9) 61 (70.1)
Educational level .809
low 149 (82.3) 78 (83.0) 71 (81.6)
high 32 (17.7) 16 (17.0) 16 (18.4)
Marital status .560





<3 years 136 (75.1) 67 (71.3) 69 (79.3)
>3 years 45 (24.9) 27 (28.7) 18 (20.7)
Dominant hand involved .950
no 35 (19.3) 19 (20.2) 16 (18.4)
yes 53 (29.3) 27 (28.7) 26 (29.9)
both hands 93 (51.4) 48 (51.1) 45 (51.7)
Direct relative with CTS 54 (29.8) 28 (29.8) 26 (29.9) .989
Paid hand labor .605
no 113 (62.4) 57 (60.6) 56 (66.4)
heavy 68 (37.6) 37 (39.4) 31 (35.6)
SSS score 2.86 (0.77) 2.89 (0.80) 2.82 (0.74) .589
FSS score 2.34 (0.89) 2.39 (0.92) 2.28 (0.86) .374
bCTQ score 2.64 (0.76) 2.68 (0.79) 2.59 (0.72) .421
Lifestyle habits
Smoking 29 (16.0) 16 (17.0) 13 (14.9) .703
alcohol 43 (23.8) 24 (25.5) 19 (21.8) .560
bMI 28.8 (5.08) 29.2 (5.24) 28.4 (4.89) .296
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DISCUSSION
Patients who received care as usual had a 2.3-fold risk of receiving carpal tunnel release surgery 
compared to patients who were treated with mechanical traction during the follow-up period. More-
over, the symptom severity had decreased significantly from baseline to follow-up in both groups, 
suggesting that not having received surgery did not result in a persistence of CTS-related symptoms. 
To date, this is the only RCT evaluating the effectiveness of mechanical traction. In 2004, Brunarski et 
al.24 published a series of four case studies in which patients with CTS received mechanical traction. 
In all four cases, symptoms improved both subjectively and objectively (measured using electro-
diagnostic studies). In an observational study among 78 patients, symptoms reduced significantly 
after mechanical traction immediately post-treatment (p <.01).25 After two years follow-up, 60% 
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Figure 2 Kaplan-Meier survival curves for the number of days after randomization until occurrence of surgery for the 
intervention and care as usual groups (log-rank test: χ2 (1, N = 181) = 6.94, p = .008).
Table 2 Comparison of CTS symptom scores at six months follow-up between the intervention and care as usual 
group.
Mean (SE) score intervention group 
(n = 94)
Mean score (SE) care as usual group 
(n = 87)
t p
SSS 1.84 (0.10) 1.89 (0.14) -.32 .747
FSS 1.75 (0.09) 1.75 (0.09) -.07 .947
bCTQ 1.80 (0.08) 1.84 (0.08) -.31 .756
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had surgery.26 A few studies have compared other non-surgical treatments with surgery. Two RCTs 
comparing steroid injections to surgery reported conflicting results; one in favor of steroid injec-
tions30 and the other in favor of surgery.18 Jarvik et al.16 compared surgery to non-surgical treatment 
(anti-inflammatory drugs, hand therapy and ultrasound therapy) in 116 patients. At six months 
follow-up, patients in the surgery group (n = 57) had significantly lower scores on the subscales SSS 
(-0.42) and the FSS (-0.46) of the BCTQ, compared to patients in the non-surgical treatment group 
(n = 59), but the clinical relevance of the difference was only modest. Surgery was more effective 
than splinting in a study by Gerritsen et al.8 However, they did not include patients with very mild or 
very severe symptoms. Altogether, evidence regarding the effectiveness of non-surgical compared 
to surgical treatment is limited and has provided conflicting results. 
In line with the current study, Baker et al.31 reported that an orthosis and stretch intervention was 
inversely related to progression to surgery at six months. In the current study, over 35% fewer 
patients underwent surgery compared to the care as usual group. Many patients do not prefer sur-
gery when there is another non-invasive treatment available. There are several reasons for patients, 
or physicians, to choose conservative treatment, including symptom severity, age, pregnancy, 
patients’ perception of the efficacy of a certain treatment, insurance, patients’ educational level, 
pregnancy (during which CTS is highly prevalent) and the presence of comorbidities.32-35
The median time to surgery was longer in the intervention group compared to the care as usual 
group, meaning surgery was delayed for approximately the duration of the intervention. There-
fore, it is not likely that a substantial number of patients will have had surgery after six months in 
the intervention group, compared to the care as usual group. Moreover, both survival curves in 
Figure 2 regress to a horizontal line, which also suggests not many people receive surgery after 
6 months in both groups. 
The CTS patients in the present investigation is comparable to CTS population in the study by 
Jarvik et al.16, based on age, gender and percentage of patients with bilateral symptoms. Jarvik et 
al. reported a mean score of 2.98 (0.70) on the SSS in their sample of CTS patients at an outpatient 
neurologic clinic (n = 116), which is very similar to the 2.86 (0.77) in the current study. Compared to 
the population of patients with electrodiagnostically confirmed CTS of Gerritsen et al.8, our study 
population is slightly older (58 vs 49), we included less women (67% vs 76%) and patients with 
more severe symptoms (mean SSS 2.9 vs 2.5). Gerritsen et al., however, applied more specific exclu-
sion criteria, excluding patients with diabetes, which could explain the difference. 
Patients included in the study did not differ from eligible patients at the outpatient neurology 
clinic based on the distribution of gender and affected hand. However, patients in the study 
were slightly older compared to eligible patients who did not participate. The main objections to 
participation were long traveling distance to the clinic and lack of time. Older people often have 
more time, because they are less likely to have young children or a fulltime job. In the care as 
usual group, there was significantly more drop-out compared to the intervention group, which 
is a common limitation of randomized controlled trials: participants may be disappointed to be 
randomized in the control group and feel less motivated to continue.36 
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A limitation of the study is the lack of discrimination between hands in bilaterally affected 
patients. Other studies only included the most severely affected hand37 or assessed both hands 
separately.38 However, it is often difficult for patients to discriminate between hands when as-
sessing symptom severity, and only including one hand in bilaterally affected patients was not 
preferable for ethical and practical reasons. Another limitation is that the response to interven-
tion was based on the patients’ symptoms perception, not by an objective measure, such as 
electrodiagnostic testing. However, electrodiagnostic testing is not sensitive enough to clinical 
change following treatment: after surgery, nerve conduction improves, but only moderately cor-
relates to patient reported improvement.39 Patient reported outcomes are considered superior in 
evaluating treatment effect and are used in most studies evaluating treatment effectiveness and 
the BCTQ is a highly validated self-reporting symptom questionnaire which is commonly used 
in clinical practice to evaluate changes of symptoms after treatment.7,16,28 Lastly, complete data 
on other forms of treatment received by patients (other than mechanical traction or surgery) 
was not available. Of the 82 completers in the intervention group, three patients had received 
a corticosteroid injection and 14 patients used a wrist splint at follow-up. Of the 56 completers 
in the care as usual group, three patients had received a corticosteroid injection and 11 used a 
wrist splint. A strength of this study is the selection of the control group. Patients in the control 
group received care as usual, and hence we compared the intervention to standard care and not 
a specific control treatment. This design leads to more generalizable results.
In conclusion, treatment by means of mechanical traction can possibly prevent progression 
of symptoms requiring surgery within six months in CTS patients. Although surgery was not 
performed in the majority of patients receiving mechanical traction, CTS symptoms declined 
significantly to a similar level as seen in CTS patients who received usual care. Because up to 30% 
of patients who received surgery report (new) CTS symptoms at longer follow-up (one to two 
years), a longer period of observation is needed to compare the long-term effect of mechanical 
traction to care as usual (including surgery). The mechanism for the effectiveness of mechanical 
traction is still unclear. We expect that the traction improves blood microcirculation, reduces 
edema in the synovial tissue, and therefore reduces pressure in the carpal tunnel.14,24 Future 
studies should focus on what the possible working mechanism is of mechanical traction. The 
clinical relevance of the current study is that by introducing a new non-invasive treatment of 
CTS, different sub-groups of CTS patients might be identified that will benefit from mechanical 
traction. This approach may result in a substantial reduction in the number of surgeries with 
similar patient-reported symptoms. Mechanical traction may prove to be a more cost-effective 
intervention for CTS than surgery. CTS is very common in the general population. Considering 
that the total cost of mechanical traction is about $420 per patient and the total cost of surgery 
about $2500, this would mean a substantial reduction in health care costs. Moreover, the current 
study contributes to the current discussion regarding the critical evaluation of the actual benefit 
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SUMMaRY aND GENERaL DISCUSSION
In this thesis, we focused on carpal tunnel syndrome (CTS) during pregnancy and the effectiveness 
of a non-invasive treatment option: mechanical traction. The chapters concerning pregnancy-
related CTS (Chapters 2, 3, 4 and 5) are based on data from the HAPPY study, a large prospec-
tive longitudinal cohort study following pregnant women during their pregnancy up to the first 
postpartum year. Chapters 6 and 7 focused on the design and results of a randomized controlled 
trial in a general, non-pregnant population investigating the effectiveness of mechanical traction. 
Carpal tunnel syndrome during pregnancy
Summary and interpretation of the main findings
In Chapter 2 we reported a prevalence of 34% of pregnancy-related CTS in our sample of 639 
women. The mean scores on the Boston Carpal Tunnel Questionnaire (BCTQ) increased towards 
the end of gestation. Still, symptom severity was generally mild to moderate. The presence of 
CTS symptoms during pregnancy was significantly related to fluid retention (OR = 1.8, 95% CI 
[1.5-2.1]), adjusted for BMI, age, parity and depression scores. Within the group of women with 
CTS symptoms, mean scores on the BCTQ independently predicted sleeping problems (β = 
0.087, p = .025) and higher depression scores based on the Edinburgh Depression Scale (EDS) 
(β = 0.237, p <.001). Fluid retention increased during gestation in all women and was related to 
CTS symptoms, which explains why CTS typically occurs in the third trimester: 40% of the cases 
reported the onset of symptoms after 30 weeks. After 30 weeks, maternal weight gain can largely 
be attributed to an increase in extravascular fluid.1 
While the prevalence of CTS in the general population is only 4-5%,2,3 the prevalence of pregnancy-
related CTS symptoms seems to be substantially higher. It is therefore important to understand 
the underlying pathophysiology of CTS during pregnancy, which might help selecting the proper 
treatment. Since CTS is related to hypothyroidism in the general population4-6 and free thyroid hor-
mone (FT4) level decreases during pregnancy,1,7 we hypothesized that pregnancy-related CTS was 
possibly associated with thyroid function. In Chapter 3, we found that lower FT4 levels at 12 and 
32 weeks’ gestation were significantly related to pregnancy-related CTS. This relation persisted at a 
multivariate level: FT4 levels in the lower quartiles (OR = 0.88, 95% CI [0.80-0.97]), higher fluid reten-
tion scores throughout pregnancy (OR = 1.78, 95% CI [1.57-2.02]) and higher depression scores 
(OR = 1.05, 95% CI [1.01-1.09]) were independently related to CTS, adjusted for BMI, age and parity. 
Moreover, the reported symptom severity of CTS was correlated with the level of fluid retention. 
Although FT4 and fluid retention were independently related to CTS, FT4 was also related to fluid 
retention. Therefore, the relation between FT4 and CTS is most likely partially mediated by fluid 
retention. However, lower FT4 levels also have a direct effect on the occurrence of the CTS, possibly 
as a result of physiological changes in peripheral nerve function leading to a slowed conduction. In 
another study, nerve conduction was significantly prolonged in women between 20 and 45 years 
old with newly diagnosed and untreated hypothyroidism.8
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Thus, CTS is a highly prevalent condition among pregnant women, but symptoms are generally 
mild. Is it just a mild discomfort during pregnancy or does it affect maternal or child well-being? 
To the best of our knowledge, there have been no previous studies investigating the possible 
impact of pregnancy-related CTS. We hypothesized that CTS symptoms may prevent women 
from starting to breastfeed their newborn. Wrist extension and flexion increase the pressure 
on the median nerve, provoking or exacerbating symptoms of paresthesia, numbness or pain,9 
possibly making it hard for a women to hold her baby during breastfeeding. In Chapter 4, 
we provided evidence to support this hypothesis. Within women with CTS, milder symptoms 
were significantly related to a higher likelihood of breastfeeding initiation. Breastfeeding is the 
best form of nutrition for infants and is promoted worldwide among new mothers.10 Mild CTS 
symptoms (OR = 1.93, 95% CI [1.10-3.36]), higher education (OR = 2.10, 95% CI [1.34-3.29]) and 
multiparity (OR = 0.61, 95% CI [0.38-0.97]) were predictive factors for breastfeeding initiation in 
women with CTS. We did not find a relationship between the presence of CTS symptoms and 
breastfeeding initiation in the sample as a whole, most likely because part of the women have 
only mild symptoms. Symptom severity and functional impairment is milder in pregnant women 
compared to the general non-pregnant population with CTS.11 This was confirmed in our RCT: 
the mean score on the BCTQ was 1.65 (0.63) during pregnancy, compared to 2.64 (0.76) in our 
general outpatient population.   
In Chapter 5, we reported that 15% of women with pregnancy-related CTS have persisting 
symptoms at 12 months postpartum. Within the group who reported CTS symptoms during 
pregnancy, higher BCTQ scores during pregnancy (OR = 1.93, 95% CI [1.08-3.45]), early onset 
of symptoms during pregnancy (OR = 2.88, 95% CI [1.45-5.72]) and higher mean EDS scores 
postpartum (OR = 1.11, 95% CI [1.03-1.19]) predicted the persistence of CTS symptoms at 12 
months postpartum. 
General methodological considerations
Prevalence rates of pregnancy-related CTS vary between 1 and 62% in the current literature.11-14 
The large variety in prevalence figures is likely due to variances in methodology. Stolp-Smith 
et al.14 reported a prevalence of 0.34% among 14,579 pregnancies in 10,873 women. They 
retrospectively analyzed medical records and only included women with a new diagnosis of 
CTS at an outpatient neurology clinic during pregnancy, which most likely resulted in a sub-
stantial underestimation. In a study by Mondelli et al.13, 45 (17%) of the 259 pregnant women 
had electrophysiologically confirmed CTS, but only women who spontaneously reported hand 
symptoms to their gynecologist were assessed. In our study, only 4 of 219 women with CTS 
symptoms consulted a physician because of their symptoms, and it is unknown how many of 
these were referred to a specialist. Padua et al.15 conducted a systematic review investigating 
the prevalence of pregnancy-related CTS. After a thorough literature search, they selected only 
five studies and reported clinically diagnosed CTS from 31% to 62% and electrophysiologically 
confirmed CTS in 7% to 43% of the cases. However, most studies were possibly affected by 
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selection bias. In an earlier prospective cohort study, Padua et al.11 found clinically diagnosed 
CTS in 62% of the pregnant women in their sample. However, they recruited women from an 
obstetrics and gynecology department and did not report any specific in- or exclusion criteria, 
while we clearly included only healthy pregnant women. Therefore, Padua et al. possibly also 
included women with primary hypothyroidism or other endocrine disorders, which increases 
the likelihood of developing CTS during pregnancy. 
People with depression in general report higher levels of somatic symptoms16, also in pregnancy.17 
In Chapter 2, however, EDS scores were not related to the presence of CTS symptoms during 
pregnancy in a multivariate analysis. On the other hand, the relationship was found during the 
postpartum period in Chapter 5. Moreover, mean EDS scores during pregnancy were a significant 
predictor of the BCTQ scores during pregnancy within women with CTS symptoms. From our 
data, it is hard to determine a causal relationship between depressive symptoms and CTS. In a 
recent meta-analysis of the literature, depression showed to be an important co-morbid factor in 
patients who suffered from chronic pain (>3 months).18 Two previous studies have investigated 
the association between psychological distress and depression on self-reported symptom severity 
in CTS patients. Nunez et al.19 found that depression predicted pain intensity in patients with CTS, 
while gender, age and electrodiagnostic parameters did not. Similarly, psychological disturbance 
(based on the hospital anxiety and depression scale) was significantly associated with BCTQ in a 
study by Hobby et al.20 It is therefore important to take depressive symptoms into consideration 
when assessing CTS. To the best of our knowledge, our study is the first to adjust for depressive 
symptoms when investigating predictors of CTS symptoms during pregnancy.
Strengths and limitations
The HAPPY study has several strengths. One is the large sample size: a large sample size reduces 
the likelihood of bias and increases external validity. Other prospective cohort studies investigat-
ing CTS during pregnancy had much smaller sample sizes, from 58 to 259.15 Another strength is 
the prospective design with multiple measurement time points. CTS was assessed at 32 weeks’ 
gestation and at one week postpartum regarding the last weeks of pregnancy. Most studies 
assessed CTS only once during pregnancy, possibly missing women who develop it during the 
last few weeks. We found that 21% reported CTS symptoms before 32 weeks’ gestation, which 
increased to 35% from 32 weeks until labor. Assessing CTS at a single time point may result in an 
underestimation of the prevalence. 
As part of the HAPPY study, women were asked “Do you experience symptoms of tingling, 
numbness or pain in hands or wrist?” in the questionnaires at 32 weeks’ gestation and one week 
postpartum regarding the last weeks of pregnancy. The questionnaires were filled out online 
or on paper. When they answered affirmative, they would then fill out the BCTQ. This means 
that women who (self ) reported CTS symptoms were not clinically or electrophysiologically 
diagnosed by a physician. There are several clinical tests to evaluate CTS, of which the Phalen’s 
test and Tinel sign are often used in scientific studies. In both tests, symptoms are provoked 
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either by holding the wrists in complete flexion (Phalen’s test) of by tapping on the wrist (Tinel 
sign). Both tests have limited diagnostic value, especially in patients with a more advanced 
form of CTS.21 The ‘gold standard’ in clinical practice to diagnose CTS is electrodiagnostic testing 
(EDT). However, it is time-consuming, expensive and uncomfortable for the patient. Therefore, 
in large longitudinal cohort studies (such as the HAPPY study) the use of EDT on all participants 
is undesirable. Moreover, the diagnosis of CTS is primarily based on the presence of patient-
reported symptoms typical for CTS (pain, tingling and numbness).22,23 Therefore, the presence of 
CTS symptoms was assessed using questionnaires in Chapters 2 through 5. Unfortunately, it is 
unclear from the data whether the CTS symptoms were present before pregnancy (and possibly 
exacerbated during pregnancy), or whether they developed during pregnancy. In the general 
population, CTS usually occurs after the age of 40. Although the exact prevalence of CTS in 
women between 18 and 40 years is unknown, the likelihood that CTS symptoms were present 
already before pregnancy is small. 
There was a considerable amount of missing data in the HAPPY study, around 30% of the partici-
pants described in Chapters 3, 4 and 5. Part of these missing data can be attributed to drop-out, 
which is a common challenge in longitudinal studies. Another major cause of missing data was 
related to practical issues, especially at one week postpartum. It was not always possible to send 
the questionnaire at the right time because childbirth is not usually planned. Out of respect for 
the rest of the new mother, we also did not send reminders after sending the questionnaire. 
However, since these causes for missing data were partly random, the risk of bias is limited. 
Comparisons of baseline characteristics between women with and without missing data were 
significantly different for some variables, but the effect sizes were generally small, meaning they 
had little, if any, clinical relevance. 
Many women in the HAPPY study were highly educated. On average, 70% had a Bachelor’s 
or Master’s degree, compared to 52% of the general Dutch female population in a similar age 
range.24 Pregnant women were recruited in and around Eindhoven, an area with a large propor-
tion of highly educated people. In 2011, the Eindhoven region was voted the smartest region in 
the world by the Intelligent Community Forum. Women with a higher education are less likely to 
work with their hands, possibly reducing the likelihood for them to develop CTS. There is some 
evidence that CTS can be work-related, especially in occupations requiring repetitive or forceful 
hand motions.25 However, CTS during pregnancy occurs mostly during the last trimester, when 
women stop working. In Chapter 3, it was shown that women who reported CTS were less highly 
educated and education was also a predictor of breastfeeding initiation (which is generally seen 
in the literature, Chapter 4). Therefore, conclusions should be interpreted with caution for less 
highly educated regions in the world. 
Implications and considerations for clinical practice 
In our study, only 2% of the pregnant women with CTS symptoms mentioned their symptoms 
to a health care provider. This is partly because symptoms are mild and are known to resolve 
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postpartum, so they do not need special attention. However, health care providers usually do 
not ask for CTS symptoms,26 which could leave the problem unrecognized. As we have shown 
in Chapters 2 and 4, CTS can have significant impact on the maternal well-being. Gynecologists 
and midwives should therefore be aware of the high prevalence. They could actively ask about 
CTS symptoms, especially during check-ups in the last trimester. To support a clinical diagno-
sis of CTS with objective measurements, ultrasonography can be used to assess the median 
nerve. Ultrasonography is readily available in obstetric departments and midwifery practices, 
it is inexpensive and non-invasive, therefore making it a more suitable diagnostic technique to 
use during pregnancy than EDT. When the symptoms present, appropriate treatment should 
be offered if necessary. Early diagnosis of CTS and subsequent treatment may prevent sleep 
problems and functional impairment in a later stage during pregnancy. Many pregnant women 
experience symptom relief with conservative treatment.12,27,28 CTS symptoms were also related 
to fluid retention. 
If symptoms could be relieved or reduced during pregnancy in women with more severe CTS, 
they may be more likely to start breastfeeding. Moreover, there are some breastfeeding positions 
that allow for a neutral position of the wrist.29 Midwives, obstetric nurses and lactation specialists 
can help new mothers to find the right positions and be comfortable during breastfeeding. 
In our study, one out of six women report persisting CTS symptoms. Timely treatment of CTS 
during pregnancy may also prevent symptoms to persist postpartum. 
Depressive symptoms should be considered in women with persisting CTS symptoms post-
partum. Women with CTS had significantly higher EDS scores in our study and higher mean 
EDS scores throughout the postpartum period were an independent predictor of persistence 
of CTS symptoms at 12 months postpartum. Women with symptoms of depression during the 
perinatal period are at increased risk for premature delivery and the child is at increased risk for 
psychological and social developmental issues.30 Women with pregnancy-related CTS should 
therefore be screened for depressive symptoms and offered an appropriate intervention. 
Directions for future research 
In non-pregnant CTS patients, symptoms are believed to be the result of wear and degenera-
tion of the tendons, leading to ischemia and, in later stages, demyelination, inflammation and 
fibrosis.23,31 The pathophysiological role of pregnancy in the development of CTS is unclear. Fluid 
retention in the synovial tissue in the carpal tunnel could lead to an increase in tissue volume 
and therefore pressure on the median nerve. Fluid retention could also cause endoneurial edema 
and thickening of the perineurium. Here, the nerve itself enlarges, creating increased pressure in 
the carpal tunnel. Fluid retention may also lead to metabolic changes, affecting nerve function.23 
Ultrasonography is a non-invasive diagnostic technique which would be able to differentiate 
between these mechanisms. In future research, pregnant women with and without symptoms 
of CTS could be compared based on ultrasonographic parameters to investigate the patho-
physiology of CTS during pregnancy. 
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In the current literature, an association between pregnancy-related CTS and the development of 
CTS later in life has not yet been investigated in a prospective study. CTS is much more common 
in women compared to men, suggesting the presence of female-specific risk factors. Future 
research could further focus on the follow-up of women with pregnancy-related CTS, to investi-
gate whether they are at risk for CTS later in life. 
Mechanical traction as non-surgical treatment option
Summary and interpretation of the main findings
We described the design of an RCT to study the effectiveness of mechanical traction in Chapter 6. 
181 adult patients from the outpatient neurology clinic of VieCuri Medical Center in Venlo, the Neth-
erlands were included in the study. All patients were clinically and electrophysiologically diagnosed 
with CTS. They were randomly assigned to either 12 treatments of mechanical traction (twice a week 
for six weeks) or care as usual. Recruitment for this study lasted from October 2013 till May 2015. In 
the process of designing the study, the sample size calculation was based on a clinically relevant 
change from baseline on the BCTQ at follow-up. To detect a mean difference of 0.5 between BCTQ 
scores of the intervention and care as usual groups, a total of 128 patients needed to be included 
with a 1:1 distribution to either group. After 19 months, as described in Chapter 7, a total number of 
181 patients were included. At 6 months follow-up, 24% did not return the questionnaire and were 
considered as drop-out. BCTQ scores were available for 138 patients, providing enough power. To 
minimize bias, we used multiple imputation for the missing BCTQ scores. 
At six months follow-up, mean BCTQ scores had significantly decreased from baseline in the 
intervention and care as usual groups, but did not differ between the groups. However, in the 
intervention group, 28% had had surgery, compared to 43% in the care as usual group. Patients 
who received care as usual had a 2.3-fold risk of having surgery during follow-up. 
Surgery is considered the most effective treatment option for CTS so far. Some patients, how-
ever, prefer initial conservative treatment, which may also be more cost-effective.32 In medicine, 
randomized controlled trials are considered to be the golden standard to evaluate the effective-
ness of a medical treatment.33 However, only a few RCTs have been conducted to study the 
effectiveness of surgery versus conservative treatment.34-36 In our study, we did not compare 
mechanical traction to strictly surgery, but to care as usual, which included steroid injections, 
wrist splints and surgery. 
General methodological considerations
Only two previous reports were available evaluating mechanical traction with a similar traction 
device as a treatment option for CTS. Brunarski et al.37 conducted a case series in which four cases 
were described. All four patients were women between 36 and 51 years old who received between 
5 and 12 treatment sessions in three months. Symptom severity and electrophysiologic measure-
ment improved in all patients. Kloosterman38 conducted an observational study among 78 CTS 
patients who were treated with mechanical traction in a practice for physical therapy in the Neth-
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erlands. The reported success rate was 70% immediately post-treatment and 60% after two year 
follow-up.39 Female gender, a positive Phalen’s test and shorter symptom duration (less than a year) 
were associated with greater improvements in symptom severity and functional status. This report, 
however, has not been published in a peer-reviewed scientific journal. Although mechanical trac-
tion is a promising form of treatment, it is not widely used in medical practice because evidence for 
treatment effectiveness was lacking so far. Therefore, we conducted a randomized controlled trial 
to compare mechanical traction to care as usual in an outpatient neurology clinic.  
Strengths and limitations 
One of the strengths of this study is the definition of the control group. We compared the interven-
tion to care as usual, which meant they would receive the standard care for CTS from their neurolo-
gist. Many patients in the care as usual group, especially those with more severe CTS, chose to have 
surgery, others adopted an expectant approach or received a wrist splint. Hence, the results are 
generalizable to a general outpatient neurology population. Comparing the intervention strictly to 
surgery would have resulted in a different patient population who would be willing to participate. 
Patients who opt for surgery generally have a more severe form of CTS. On the other hand, com-
paring mechanical traction to another non-invasive treatment (for example splinting or steroid 
injections) would have led to a sample with milder CTS. In the current study, the included patients 
did not differ from eligible patients at the outpatient neurology clinic based on the distribution of 
gender and affected hand. However, included patients were slightly older. 
We followed the design described in Chapter 6 in conducting the RCT, with the exception of 
part of the statistical analyses. Initially, treatment success was defined as a significantly greater 
reduction in BCTQ score in the intervention group compared to the care as usual group. How-
ever, patients in the intervention group were free to have additional treatment if the 12 sessions 
of mechanical traction did not lead to the desired reduction in symptom severity. Consequently, 
26 patients in the intervention group had received surgery at six months follow-up. Data were 
analyzed based on the intention-to-treat principle, resulting in no significant difference in BCTQ 
scores between the two groups. However, 26 (28%) patients in the intervention group had sur-
gery, compared to 37 (43%) in the care as usual group. A reduction in the number of surgeries 
with a similar reduction in symptom severity would also be a favorable outcome. A non-invasive 
treatment is often preferred over a more invasive option by patients, such as surgery. The num-
ber of surgeries were therefore compared between both groups using Kaplan Meier survival 
analysis, a statistical method that is widely used in clinical trials to assess time-to-event. The 
log-rank test is used to compare time-to-event curves between groups. 
There was a proportion of missing data at six months follow-up. Of the 181 patients who were 
included in the study, 138 (76%) returned the questionnaire at six months. Of the remaining 24%, 
missing data were imputed using multiple imputation, based on baseline characteristics and 
BCTQ scores. Whether a patient had surgery was checked in the medical record of the hospital. 
Therefore, data on carpal tunnel surgery was complete at six months follow-up.
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Implications and considerations for clinical practice 
In the Netherlands, patients with CTS symptoms consult their general practitioner before visit-
ing a specialist. Only 25% of clinically diagnosed CTS patients are referred to a neurology clinic 
by general practitioners for electrodiagnostic testing and treatment.40 This means that many 
patients, with probably milder symptoms, receive treatment by their general practitioner or no 
treatment at all. Mechanical traction would be especially suitable for these patients, because the 
treatment is non-invasive and low-risk. In our study, three patients did not finish the intervention 
of 12 treatment sessions, mainly because symptom severity increased during this period and 
mechanical traction was not effective. However, no adverse effects were reported. Therefore, 
patients with milder symptoms do not necessarily need a (time consuming and expensive) 
electrophysiologically confirmed diagnosis before starting treatment. If general practitioners 
would start to refer CTS patients for mechanical traction, this would lead to a more timely treat-
ment at an earlier stage of the syndrome, possibly increasing the likelihood of success. Because 
mechanical traction is a non-invasive, cheap and readily accessible treatment, it could be seen as 
a first-line treatment option for CTS. If mechanical traction fails, surgery is still an option without 
any evidence for poorer prognosis. 
It is interesting to note that – although not discussed in this thesis – we also explored the inde-
pendent effect of depressive symptoms on CTS symptoms in the sample of patients included 
in the RCT. Again, depressive symptoms proved to be a strong predictor of BCTQ scores. As we 
have stated previously, depression is related to pain,18 also in patients with CTS.19,20 This sug-
gests that, when evaluating the severity of CTS symptoms, it is always wise to investigate the 
co-existence of depression. It is obvious that surgery might not be the first choice of treatment 
for CTS patients with depression. Because depression, until now, has never been assessed at an 
outpatient neurology clinic of CTS patients, it might be speculated whether the poor response 
to surgery occurs especially in depressed patients. 
Directions for future research 
Several other possible positive outcomes of mechanical traction compared to care as usual have 
not yet been explored, such as days of sick leave from work or health care utilization. After CTS sur-
gery, the average return to work is between two and seven weeks. During the period of treatment 
with mechanical traction, however, people can continue work and all other daily activities. Initial 
treatment with mechanical traction may therefore also be more cost-effective. In the Netherlands, 
about 27,500 CTS patients received carpal tunnel release surgery in 2011.41 The introduction of 
mechanical traction as the primary treatment for CTS could reduce the surgery rate by roughly 
35% with similar patient reported outcomes. Considering that the total cost of mechanical traction 
is about €360 per patient and the total cost of surgery about €2500, this would mean a possible 
annual saving of 14 million euros in the Netherlands alone. If similar data could be extrapolated 
to the US with almost 20 times more inhabitants compared to the Netherlands and a similar high 
standard health care system, a reduction of surgery by 35% would imply an annual saving of health 
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costs of 280 million euros. However, a longer follow-up time is needed to explore these outcomes. 
It is unknown whether the mechanical traction is also effective long-term, or merely postpones 
further treatment. Moreover, it is unclear who benefits most from mechanical traction. Treatment 
success could vary based on gender, age or symptom severity. 
Connecting both studies: CTS during pregnancy and mechanical traction
CTS during pregnancy is often treated conservatively, since symptoms quickly resolve after 
childbirth in the majority of women. Surgery is only performed during pregnancy in very severe 
cases.28 Mechanical traction would be an especially suitable non-invasive treatment option 
during pregnancy. Bilateral symptoms are more common during pregnancy compared to the 
non-pregnant CTS population. In Chapter 2, 70% of the pregnant women with CTS reported 
bilateral symptoms. In our non-pregnant, outpatient population, only 51% had bilateral symp-
toms. Mechanical traction is useful for (pregnant) patients with bilateral symptoms, because 
both hands can be treated during one treatment session. However, it is unknown whether the 
pathophysiology of CTS during pregnancy is similar to idiopathic CTS. Mechanical traction is 
expected to reduce pressure in the carpal tunnel by improving blood microcirculation and 
reducing oedema in the synovial tissue.37,42 Whether this mechanism also applies during preg-
nancy remains to be investigated. Mechanical traction could therefore be less effective, or more 
effective in women with pregnancy-related CTS compared to a general outpatient population 
with idiopathic CTS. Ultrasonography could be used to examine the changes in the tissue of the 
carpal tunnel after treatment with mechanical traction, also in pregnancy.
In both studies, depressive symptoms at the time of diagnosis were independently related to the 
severity and persistence of symptoms. If depressive symptoms are also a predictor of treatment 
failure, outpatient clinics should consider the co-occurrence of depressive symptoms in CTS 
patients before surgery is offered. It might be more appropriate to first treat depression. Future 
research should focus on the effect of depressive symptoms on treatment outcome. 
General conclusion
CTS occurs in one out of three healthy pregnant women and in one out of six of these women 
symptoms still persist at 12 months postpartum. Thyroid hormone changes during pregnancy 
are possibly related to the occurrence of CTS symptoms, most likely mediated by increased lev-
els of fluid retention in those women with low thyroid hormone levels. Moreover, women with 
more severe CTS symptoms are less likely to initiate breastfeeding compared to women with 
milder symptoms. Mechanical traction shows beneficial effects at six months follow-up. Due to 
its non-invasive character, it seems to be an excellent treatment option for pregnant women 
with CTS. Whenever pregnant women or patients at an outpatient neurology clinic report high 
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Carpaletunnelsyndroom (CTS) is een neurologische aandoening waarbij de middelste handze-
nuw (nervus medianus) is bekneld ter hoogte van de carpale tunnel. De carpale tunnel is een 
ruimte in de pols, omgeven door de handwortelbeentjes en het carpale ligament. De beknelling 
van de middelste handzenuw leidt tot symptomen van doofheid, tintelingen en soms pijn in de 
hand(en). De symptomen uiten zich voornamelijk in de eerste drie vingers van de hand en de 
radiale zijde van de ringvinger, het deel van de hand dat wordt geïnnerveerd door de middelste 
handzenuw, en ontstaan meestal ’s nachts. CTS komt vaak voor: de prevalentie in de algemene 
populatie is ongeveer 5%. Het komt vaker voor bij mannen dan bij vrouwen en ontstaat meestal 
tussen de leeftijd van 40 en 60 jaar. De diagnose van CTS is voornamelijk gebaseerd op patiënt-
gerapporteerde klinische symptomen. In de meeste gevallen ontstaat CTS spontaan. Er zijn 
echter aandoeningen die de kans op het ontstaan van CTS vergroten, waaronder overgewicht, 
diabetes, reuma, tenosynovitis en hypothyreoïdie. De prevalentie van CTS onder hypothy-
reoïdie patiënten is meer dan 30%. Zwangerschap is ook een bekende risicofactor voor CTS. 
Zwangerschaps-gerelateerde CTS is vaker bilateraal en ontstaat meestal in het derde trimester. 
De prevalentie van CTS in de zwangerschap varieert tussen 1 en 62% in de huidige literatuur. 
In dit proefschrift worden de resultaten van twee verschillende studies beschreven. De eerste 
studie is de HAPPY studie, een observationele studie onder 2,221 vrouwen die we hebben 
gevolgd tijdens hun zwangerschap en het eerste jaar postpartum. Met behulp van deze data 
hebben we prevalentie, determinanten en mogelijke (negatieve) effecten van CTS tijdens de 
zwangerschap onderzocht. De tweede studie is een gerandomiseerde en gecontroleerde studie 
(randomized controlled trial, RCT) waar het effect van mechanische tractie van de pols als non-
invasieve behandeling voor CTS is onderzocht onder CTS patiënten (mannen en vrouwen) van 
een polikliniek neurologie. 
CTS komt vaak voor tijdens de zwangerschap, maar de exacte prevalentie is onduidelijk. In 
Hoofdstuk 2 hebben we daarom de prevalentie van CTS symptomen onderzocht in 639 zwan-
gere vrouwen van de HAPPY studie. De ernst van de klachten werd gemeten met de Boston 
Carpal Tunnel Questionnaire (BCTQ), een gevalideerde vragenlijst die de mate van symptomen 
en functionele beperking meet. 34% van deze vrouwen rapporteerde CTS klachten tijdens de 
zwangerschap en de ernst nam toe naar het einde van de zwangerschap. Ten opzichte van 
de algemene, niet-zwangere CTS patiëntenpopulatie is de ernst van de symptomen tijdens de 
zwangerschap relatief mild. De aanwezigheid van CTS symptomen was gerelateerd aan het 
vasthouden van vocht. Binnen de groep van vrouwen met CTS symptomen was de ernst van 
de klachten gerelateerd aan slaapproblemen en hogere depressie scores, gebaseerd op de Edin-
burgh Depression Scale (EDS). Het is belangrijk om te controleren voor de mentale gesteldheid, 
in het bijzonder depressie, wanneer patiënt-gerapporteerde symptomen worden gemeten is. 
Depressie kan van invloed zijn op de subjectieve pijnervaring. 
 Hypothyreoïdie, een aandoening waarbij het lichaam te weinig schildklierhormoon (thyroxine, 
FT4) aanmaakt, is een risicofactor voor het ontstaan van CTS. FT4 daalt tijdens de zwangerschap, 
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maar een relatie tussen schildklierfunctie en CTS in de zwangerschap is tot op heden niet on-
derzocht. In Hoofdstuk 3 laten we zien dat lagere FT4 levels op 12 en 32 weken zwangerschap, 
hogere scores op zelf-gerapporteerd vocht vasthouden en hogere depressie scores onafhanke-
lijk waren gerelateerd aan CTS.
CTS komt dus vaak voor bij zwangere vrouwen, maar de symptomen zijn relatief mild. Is het 
enkel een ongemak tijdens de zwangerschap, of heeft het mogelijk ook effect op het welzijn van 
moeder en kind? In Hoofdstuk 4 beschrijven we dat, binnen de groep zwangere vrouwen met 
CTS symptomen, vrouwen met mildere symptomen vaker startten met het geven van borstvoe-
ding na de bevalling ten opzichte van vrouwen met ernstigere symptomen. Extensie en flexie 
van de pols kan de druk op de middelste handzenuw vergroten, waardoor de CTS symptomen 
kunnen verergeren. Dit maakt het mogelijk lastig en/of pijnlijk voor een vrouw om haar baby 
(gedurende langere tijd) vast te houden tijdens het geven van borstvoeding. 
CTS symptomen verminderen of verdwijnen vaak na de bevalling, maar een deel van de vrouwen 
blijft persisterende klachten houden postpartum. Van de vrouwen met CTS symptomen heeft 
15% persisterende klachten tot 12 maanden postpartum, zoals gerapporteerd in Hoofdstuk 5. 
Hogere BCTQ scores tijdens de zwangerschap, het vroeg ontstaan van de symptomen en hogere 
depressie scores op de EDS postpartum voorspelden het persisteren van CTS symptomen tot 12 
maanden postpartum. 
In de algemene, niet-zwangere populatie wordt CTS conservatief of operatief behandeld. CTS 
wordt meestal conservatief behandeld wanneer de klachten nog maar kort bestaan of mild zijn. 
De meest gebruikte conservatieve behandelingen zijn een polsspalk of steroïde injectie in de 
carpale tunnel. Beide behandelopties zijn effectief op korte termijn, maar bewijs voor effect op 
de lange termijn is schaars. Een CTS operatie, waarbij het carpale ligament gekliefd wordt, is de 
enige behandeling die effectief is op lange termijn. Het is echter een invasieve methode en 30% 
van de patiënten ervaren aanhoudende symptomen, operatieve complicaties of een terugkeer 
van de symptomen. Mechanische tractie uitgeoefend op de pols is een veelbelovende, con-
servatieve behandeloptie voor CTS. Tijdens deze behandeling wordt er herhaaldelijk trekkracht 
uitgeoefend op de pols met behulp van een gewicht. In Hoofdstuk 6 wordt het design van 
een RCT beschreven waarbij 12 behandelingen met mechanische tractie gedurende zes weken 
wordt vergeleken met de gebruikelijke zorg (care as usual). De resultaten van deze RCT worden 
beschreven in Hoofstuk 7. In totaal werden 181 volwassen CTS patiënten (mannen en vrouwen) 
geïncludeerd van de polikliniek Neurologie van het VieCuri Medisch Centrum in Venlo/Venray, 
Nederland. Alle patiënten hadden een klinische CTS diagnose, welke was bevestigd door middel 
van elektrofysiologisch onderzoek. Al deze patiënten werden gerandomiseerd in één van de 
twee groepen: interventie (mechanische tractie) of de controle groep (gebruikelijke zorg). Zij 
vulden vragenlijsten in bij de start van het onderzoek en na 3, 6 en 12 maanden. Na 6 maanden 
was de gemiddelde BCTQ score (ernst van de symptomen) significant gedaald ten opzichte van 
de start van het onderzoek in beide groepen, maar er was geen verschil tussen de groepen. 




was op dat moment 28% van de patiënten geopereerd, ten op zicht van 43% in de controle 
groep. Mechanische tractie heeft een aantal voordelen. Het is non-invasief: patiënten ervaren 
over het algemeen geen pijn of ongemak van de behandeling en kunnen hun dagelijkse be-
zigheden blijven doen. Patiënten met bilaterale symptomen kunnen behandeld worden aan 
beide handen tijdens dezelfde sessie en de behandeling kan door middel van de gewichten 
en het aantal sessies worden aangepast aan de behoefte van individuele patiënten. Wanneer 
mechanische tractie niet effectief is, is een operatie alsnog een optie. 
Implicaties voor de praktijk
De prevalentie van CTS in de algemene populatie is ongeveer 5%, terwijl de prevalentie van CTS 
in de zwangerschap veel hoger ligt. Het is daarom belangrijk het probleem te onderkennen en 
de onderliggende pathofysiologie te begrijpen, wat mogelijk kan helpen met het kiezen van de 
juiste behandeloptie. Een tijdige diagnose van CTS en behandeling kan mogelijk slaapproble-
men en functionele handproblemen later in de zwangerschap voorkomen. Tijdige behandeling 
tijdens de zwangerschap voorkomt mogelijk ook het persisteren van klachten postpartum.
In Nederland wordt ongeveer 25% van de patiënten met een klinische CTS diagnose doorverwe-
zen door de huisarts naar een polikliniek neurologie. De overige patiënten worden behandeld 
door hun huisarts of krijgen geen behandeling. Mechanische tractie zou uitermate geschikt zijn 
voor deze patiënten omdat het non-invasief is en een laag risico met zich mee draagt. Opera-
tieve behandeling wordt gezien als de meest effectieve optie, maar sommige patiënten geven 
aanvankelijk een voorkeur aan conservatieve behandeling, wat ook meer kosteneffectief kan 
zijn. Mechanische tractie is daarom geschikt als primaire behandeloptie, waarna patiënten die 
er geen baat bij hebben alsnog kunnen worden geopereerd. Mechanische tractie is mogelijk 
ook een geschikte behandeloptie voor CTS tijdens de zwangerschap. CTS is vaker bilateraal in 
zwangere vrouwen vergeleken met de algemene populatie. Het is echter nog niet bekend of de 
pathofysiologie van zwangerschaps-gerelateerde CTS gelijk is aan spontaan CTS. 
Conclusie
Een derde van de zwangere vrouwen ervaart CTS symptomen in de zwangerschap en een zesde 
van deze vrouwen (5% van alle zwangere vrouwen) houdt klachten tot 12 maanden postpartum. 
Veranderingen in schildklierhormoon concentraties en het vast houden van vocht zijn mogelijk 
gerelateerd aan het ontstaan van CTS symptomen in de zwangerschap. Vrouwen met ernstigere 
CTS symptomen geven minder vaak borstvoeding dan vrouwen met mildere symptomen. Be-
handeling voor CTS met mechanische tractie resulteert in minder operaties na 6 maanden. Het 
is non-invasief en daarom mogelijk een zeer geschikte behandeloptie voor zwangere vrouwen 
met CTS symptomen. 
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bOSTON CaRPaL TUNNEL QUESTIONNaIRE (bCTQ)
Klachtenscore
1. Hoe ernstig is de pijn in uw hand(en) of pols(en) ‘s nachts?
 1 Ik heb geen pijn in mijn hand of pols ‘s nachts  
 2. De pijn is mild  
 3 De pijn is behoorlijk 
 4 De pijn is ernstig 
 5 De pijn is nauwelijks te verdragen 
2. Hoe vaak wordt u wakker van de pijn gedurende de nacht? 
 1 Nooit
 2 1 maal
 3 2 - 3 maal
 4 4 - 5 maal
 5 > 5 maal
3. Heeft u overdag ook pijn in uw hand(en) of pols(en)? 
 1 Ik heb nooit pijn overdag  
 2 Ik heb milde pijn overdag 
 3 Ik heb behoorlijk veel pijn overdag  
 4 Ik heb ernstige pijn overdag  
 5 Ik heb nauwelijks te verdragen pijn overdag 
4. Hoe vaak heeft u pijn overdag? 
 1 Nooit
 2 1 maal
 3 2 - 3 maal
 4 4 - 5 maal
 5 > 5 maal
5. Hoe lang duurt zo’n periode met pijn gemiddeld overdag?
 1 Ik heb geen pijn
 2 < 10 min
 3 10 - 60 min
 4 > 1 uur
 5 Constant aanwezig
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6. Heeft u een doof gevoel of last van gevoelloosheid in uw hand(en)? 
 1 Nooit
 2 Een beetje
 3 Behoorlijk
 4 Ernstig
 5 Zeer ernstig
7. Heeft u krachtsverlies (zwakte) van de hand(en)?
 1 Nee
 2 Een beetje
 3 Behoorlijk
 4 Ernstig
 5 Ik kan er bijna niets meer mee
8. Heeft u tintelingen of een slapend gevoel in uw hand(en)? 
 1 Nee
 2 Een beetje
 3 Behoorlijk
 4 Ernstig
 5 Zeer ernstig
9. Hoe ernstig zijn het dove gevoel of de tintelingen ‘s nachts? 




 5 Zeer ernstig
10. Hoe vaak wordt u wakker van een doof gevoel of tintelingen? 
 1 Nooit
 2 1 maal
 3 2 - 3 maal
 4 4 - 5 maal
 5 > 5 maal
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11.  Heeft u problemen met het vastpakken van kleine voorwerpen, bijvoorbeeld sleutels of een 
balpen?
 1 Geen
 2 Een beetje problemen
 3 Behoorlijk wat problemen
 4 Ernstige problemen
 5 Ik kan zulke voorwerpen helemaal niet vastpakken
Functionele score
Kunt u aangeven hoeveel moeite u heeft ervaren, vanwege hand of polsklachten, bij het uitvoe-
ren van onderstaande activiteiten op een voor u normale dag gedurende de afgelopen twee 






















































Schrijven 1 2 3 4 5 
Knopen  vastmaken 1 2 3 4 5 
Een boek vasthouden bij het lezen 1 2 3 4 5 
Een telefoon / mobieltje vasthouden 1 2 3 4 5 
Een potje openmaken 1 2 3 4 5 
Huishoudelijk werk verrichten 1 2 3 4 5 
Tassen dragen 1 2 3 4 5 
Wassen/aankleden 1 2 3 4 5 
Naar: Köke AJA, Heuts PHTG, Vlaeyen JWS, Weber WEJ. Meetinstrument: Functionele Handicap Score. 







De afgelopen drie jaar heb ik met veel plezier aan de onderzoeken en dit proefschrift gewerkt. 
Ik ben trots op het resultaat, maar dit heb ik natuurlijk niet alleen aan mezelf te danken. Via deze 
weg wil ik graag iedereen bedanken die, direct of indirect, aan dit proefschrift heeft bijgedragen. 
Allereerst mijn promotores en copromotor, die de moeite hebben genomen om hun kennis over 
te dragen en mij het vertrouwen hebben gegeven om dit proefschrift af te leveren. Prof.dr. Pop, 
beste Victor, het is onvoorstelbaar wat ik in drie jaar tijd onder jouw begeleiding heb geleerd. 
Bedankt voor je tijd, moeite en aanstekelijke enthousiasme voor onderzoek en statistiek. Onze 
overlegmomenten zijn altijd even efficiënt als motiverend. Prof.dr. Visser, hartelijk dank voor uw 
betrokkenheid en leerzame feedback. Uw kritische blik en nauwkeurigheid zijn de kwaliteit van 
de papers zeker ten goede gekomen. Dr. Spek, beste Viola, ik vond het erg fijn dat je in de loop 
van het project erbij werd betrokken. Jouw frisse kijk, praktische tips en opbouwende feedback 
hebben mij erg geholpen. 
De overige leden van de commissie, Prof.dr. Oei, Prof.dr. Van Oostenbrugge, Prof.dr. Pouwer, Dr. Her-
mans en Dr. Kuppens, wil ik hartelijk bedanken voor het lezen en beoordelen van dit proefschrift . 
Alle neurologen van VieCuri Medisch Centrum, hartelijk dank voor jullie inzet om patiënten met 
CTS te includeren in de trial. Ook alle medewerkers van de poli Neurologie en KNF laboranten 
van VieCuri Medisch Centrum, dankjewel voor alle stukken vlaai, gezelligheid in de koffiekamer 
en hulp met praktische zaken. 
Alle deelnemers van beide studies (CTS patiënten van VieCuri Medisch Centrum en deelnemers 
van de HAPPY-studie) wil ik hartelijk bedanken voor hun tijd en betekenisvolle bijdrage aan 
wetenschappelijk onderzoek. 
Sophie, Carola en alle ander medewerkers van de HAPPY-studie, heel erg bedankt voor het mede 
mogelijk maken van de fantastische dataset waarmee ik heb mogen werken. 
Alle co-auteurs, Prof.dr. Kop, Dr. Den Oudsten, Dr. Broeren, wil ik graag bedanken voor jullie bijdrage 
aan de verschillende artikelen en leerzame feedback. 
Iedereen die heeft geholpen met de Phystrac en de trial, hartelijk dank daarvoor: Rob Oostenrijk 
voor het wegwijs maken met de Phystrac, Richard de Muinck en andere medewerkers van DEMCA 
voor de service van de Phystrac en Parelinvest, in het bijzonder Gert Jan Kleinrensink, voor het 
sponsoren van de trial. 
Collega’s van de afdeling Medische en Klinische Psychologie van Tilburg University, dankjewel 
voor de relatief korte, maar gezellige tijd met jullie! 
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Dankwoord
Mijn paranimfen, mijn zus Henriët en schoonzus Kiona, super bedankt dat jullie (letterlijk en 
figuurlijk) achter mij staan!
Lieve Jet, ik was jouw paranimf, nu ben jij de mijne! Ik vind het super gaaf om dit te kunnen delen 
met jou. Dankjewel voor jouw geruststellende woorden en vertrouwen in mij. 
Lieve Kiona, het is bijzonder om een schoonzus te hebben die ook nog eens zo’n goede vriendin 
is geworden. Als ik even wil sparren ben jij meestal de eerste die ik een berichtje stuur en je hebt 
altijd wel iets zinnigs (en ook veel onzinnigs ;) ) te zeggen. Dankjewel daarvoor! 
Lieve familie en schoonfamilie, heel erg bedankt voor jullie interesse en steun de afgelopen 
jaren. In het bijzonder natuurlijk mijn ouders: 
Lieve papa, bij jou begon het allemaal. Toen Victor in 2013 bij de neurologen van VieCuri met 
het voorstel kwam voor de trial, dacht jij gelijk aan jouw jongste dochter die over een aantal 
maanden zou afstuderen en op zoek zou gaan naar haar eerste baan. Dat zoeken is me bespaard 
gebleven, want in no-time was alles geregeld: 31 augustus 2013 afgestudeerd, 1 september 
2013 mijn eerste werkdag. Ik vond het ontzettend leuk om een werkplek met je te mogen delen, 
al jouw collega’s te leren kennen en op die manier ook dat deel van jouw leven beter te leren 
kennen. 
Lieve mama, dankjewel dat je altijd voor me klaar staat. Jij hebt aan twee woorden genoeg 
om te weten wat ik nodig heb en hebt altijd een nuttig advies voor me, maakt niet uit wat het 
probleem is. 
Teamies van Mikey’s Downhill & Enduro Team, dankjewel voor alle gezelligheid en sportieve 
uitdagingen! Jullie hoef ik niet uit te leggen waarom een Fox 40 een topvork is, dat downhill me-
gazwaar is ook al fiets je niet naar boven, en dat een goggle op een normale helm SO ENDURO 
is, maar ook heel lelijk. Onze bike adventures en mijn promotie waren altijd goed te combineren: 
ik heb een paar maanden geleden nog in mijn proefschrift gelezen in een EHBO wachtkamer in 
Frankrijk. 
Mijn lieve vriend, Maichel, jouw positieve kijk op het leven, eeuwige lach op je gezicht en on-
uitputtelijke energie hebben mij door alle ups en downs geholpen. Er is super veel gebeurd en 
veranderd in de afgelopen 3 jaar en ik ben blij dat ik dat allemaal met jou mag meemaken. Ik kan 
niet wachten om te zien wat er allemaal nog meer op ons pad komt! 
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